company,date,payment_type,study,PI,payment
"Alkermes, Inc.",2016-01-01,In-kind items and services,"A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder",373291,75
"Alkermes, Inc.",2016-01-01,In-kind items and services,"A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder",373291,140.8
Vertex Pharmaceuticals Incorporated,2016-01-01,Cash or cash equivalent,Clearing Lungs with ENAC Inhibition in Cystic Fibrosis,826949,9584.1
Vertex Pharmaceuticals Incorporated,2016-01-01,Cash or cash equivalent,"A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation",826949,88198.18
"Varian Medical Systems, Inc.",2016-01-04,Cash or cash equivalent,Real-time delivery with EPID -U.V.,NA,7e4
Emergent Biosolutions Inc.,2016-01-05,Cash or cash equivalent,RSDL,NA,4800
"E.R. Squibb & Sons, L.L.C.",2016-01-05,Cash or cash equivalent,Melanoma Biomarker CA210 002,157351,169094.36
"Medtronic USA, Inc.",2016-01-05,Cash or cash equivalent,APOLLO,123252,2967
"AbbVie, Inc.",2016-01-07,Cash or cash equivalent,P12-792,826949,500
Allergan Inc.,2016-01-07,Cash or cash equivalent,LONG-TERM STUDY IN US CYSTIC FIBROSIS PATIENTS RECEIVING DIGESTIVE ENZYME SUPPLEMENTS TO ASSESS ANY NARROWING OF THE LARGE INTESTINES CAUSING ADVERSE INTESTINAL SYMPTOMS FIBROSING COLONOPATHY,826949,1063.83
AxoGen,2016-01-07,Cash or cash equivalent,Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair RECON,108413,1e4
"InSightec,LTD",2016-01-07,Cash or cash equivalent,A Clinical Study to Evaluate Safety of the ExAblate Model 2100 Type 1.1 System (ExAblate 2100/2000 UF V2 System) in the Treatment of Symptomatic Uterine Fibroids,147662,22205.5
Novartis Pharmaceuticals Corporation,2016-01-08,Cash or cash equivalent,A MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF THE SAFETY TOLERABILITY AND EFFECTS ON ARTERIAL STRUCTURE AND FUNCTION OF ACZ885 IN PATIENTS WITH INTERMITTENT CLAUDICATION,1061444,39594.33
"Seattle Genetics, Inc.",2016-01-12,Cash or cash equivalent,SG0350014,366054,620.04
"AbbVie, Inc.",2016-01-13,Cash or cash equivalent,M14-011,596090,787.67
Astellas Pharma Global Development,2016-01-14,Cash or cash equivalent,Assessment of Myocardial Flow Reserve (and Effects of Exercise Traiing in Patients with Angina and Negative Coronary Angiograms,203646,52877.91
AstraZeneca Pharmaceuticals LP,2016-01-15,Cash or cash equivalent,Affordability and Real world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Current patterns of P2Y12 receptor inhibitor use provide an excellent opportunity to test the impact of copayment reduction on clinician choice of medication patient adherence and clinical outcomes,1043167,16200
"Pharmacyclics LLC, An AbbVie Company",2016-01-15,Cash or cash equivalent,PCYC-1112-CA,744701,3464.99
Cook Research Incorporated,2016-01-18,Cash or cash equivalent,TX2 Post-approval Study,259543,100
"MicroVention, Inc.",2016-01-18,Cash or cash equivalent,HEAT,355275,13608
The Spectranetics Corporation,2016-01-18,Cash or cash equivalent,ILLUMENATE PIVOTAL,300280,5625
AstraZeneca Pharmaceuticals LP,2016-01-19,Cash or cash equivalent,Upstream Ticagrelor Registry Study,264241,14025
Boston Scientific Corporation,2016-01-19,Cash or cash equivalent,CAP2 - PREVAIL CONTINUED ACCESS REGISTRY,217198,500
Emergent Biosolutions Inc.,2016-01-19,Cash or cash equivalent,RSDL,824482,4200
Kadmon Corporation LLC,2016-01-20,Cash or cash equivalent,A Phase 1b 2a Safety Pharmacokinetic and Dose Escalation Study of KD019 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,66723.75
Kadmon Corporation LLC,2016-01-20,In-kind items and services,A Phase 1b 2a Safety Pharmacokinetic and Dose Escalation Study of KD019 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,5813.35
"St. Jude Medical, Inc.",2016-01-20,Cash or cash equivalent,ADVANCE ASO,217198,19923.5
Boston Scientific Corporation,2016-01-21,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,3510.01
Vertex Pharmaceuticals Incorporated,2016-01-21,Cash or cash equivalent,An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis,826949,12654.69
Vertex Pharmaceuticals Incorporated,2016-01-21,Cash or cash equivalent,"A Phase 3 Study of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor",826949,10.42
"Pharmacyclics LLC, An AbbVie Company",2016-01-25,Cash or cash equivalent,PCYC-1104-CA,12841,3851.77
"E.R. Squibb & Sons, L.L.C.",2016-01-26,Cash or cash equivalent,A Safety Trial of Nivolumab BMS 936558 in Subjects With Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen CheckMate 153,768804,36535
Novartis Pharmaceuticals Corporation,2016-01-26,Cash or cash equivalent,A 12 MONTH RANDOMIZED RATER AND DOSE BLINDED STUDY TO COMPARE THE EFFICACY AND SAFETY OF FINGOLIMOD TWENTY FIVE HUNDREDTH OF A MG AND HALF OF A MG ADMINISTERED ORALLY ONCE DAILY WITH GLATIRAMER ACETATE 20 MG ADMINISTERED SUBCUTANEOUSLY ONCE DAILY IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS,74842,17230.07
SANOFI US SERVICES INC.,2016-01-26,Cash or cash equivalent,ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727),NA,112.68
SANOFI US SERVICES INC.,2016-01-27,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,1e3
"Siemens Medical Solutions USA, Inc.",2016-01-27,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,17987.5
Abbott Laboratories,2016-01-28,Cash or cash equivalent,EVEREST II,217198,2835
Novartis Pharmaceuticals Corporation,2016-01-28,Cash or cash equivalent,A 24 MONTH RANDOMIZED CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CONCENTRATION CONTROLLED EVEROLIMUS PLUS REDUCED TACROLIMUS COMPARED TO STANDARD TACROLIMUS IN RECIPIENTS OF LIVING DONOR LIVER TRANSPLANTS,19951,52057.6
Novo Nordisk AS,2016-01-28,Cash or cash equivalent,NN7008-3809,500528,1419.2
"Actelion Pharmaceuticals US, Inc.",2016-01-29,Cash or cash equivalent,OPUS - AC-055-503,199176,2525
Edwards Lifesciences Corporation,2016-01-29,Cash or cash equivalent,The PARTNER Trial Placement of Aortic Transcatheter Valve Trial 2006-06,217198,2600
Edwards Lifesciences Corporation,2016-01-29,Cash or cash equivalent,The PARTNER II Trial Placement of Aortic Transcatheter Valve Trial 2010-12,123007,27400
"Genentech, Inc.",2016-01-29,Cash or cash equivalent,APDL1 BLADDER EAP,266016,11687
"Zimmer Biomet Holdings, Inc.",2016-01-29,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,2937.5
"Alkermes, Inc.",2016-02-01,In-kind items and services,"A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder",373291,75
Boston Scientific Corporation,2016-02-01,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,3105
"InSightec,LTD",2016-02-01,Cash or cash equivalent,A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects,NA,123265
SANOFI US SERVICES INC.,2016-02-01,Cash or cash equivalent,Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis (FUSCIA),594186,1238
"Takeda Development Center Americas, Inc.",2016-02-02,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder",316643,3750
"Takeda Development Center Americas, Inc.",2016-02-02,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder",316643,8938
The Medicines Company,2016-02-03,Cash or cash equivalent,ENDOVASCULAR INTERVENTIONS WITH ANGIOMAX THE ENDOMAX TRIAL,NA,400
Novartis Pharmaceuticals Corporation,2016-02-04,Cash or cash equivalent,A RANDOMIZED OPEN LABEL PHASE II STUDY OF WEEKLY GEMCITABINE PLUS PAZOPANIB VERSUS WEEKLY GEMCITABINE ALONE IN THE TREATMENT OF PATIENTS WITH PERSISTENT OR RELAPSED EPITHELIAL OVARIAN FALLOPIAN TUBE OR PRIMARY PERITONEAL CARCINOMA,945020,1345796.49
Novo Nordisk AS,2016-02-04,Cash or cash equivalent,NN7008-3809,500528,2069.5
"Alexion Pharmaceuticals, Inc.",2016-02-05,Cash or cash equivalent,Atypcial Hemolytic-Uremic Syndrome aHUS Registry,244226,375
Bayer HealthCare Pharmaceuticals Inc.,2016-02-05,Cash or cash equivalent,BAY73 4506 eye drop wAMD,19168,3500
Vertex Pharmaceuticals Incorporated,2016-02-06,Cash or cash equivalent,A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation,826949,7808.62
F. Hoffmann-La Roche AG,2016-02-08,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,3757
"Alexion Pharmaceuticals, Inc.",2016-02-09,Cash or cash equivalent,"A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function.",104164,8673
"Otsuka Pharmaceutical Development & Commercialization, Inc.",2016-02-10,Cash or cash equivalent,EFFICACY AND SAFETY OF TOLVAPTAN IN SUBJECTS WITH CHRONIC KIDNEY DISEASE BETWEEN LATE STAGE 2 TO EARLY STAGE 4 DUE TO AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE,279373,16464.34
"Siemens Medical Solutions USA, Inc.",2016-02-10,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,75.6
"St. Jude Medical, Inc.",2016-02-10,Cash or cash equivalent,SCORE,25612,625
The Medicines Company,2016-02-10,Cash or cash equivalent,ENDOVASCULAR INTERVENTIONS WITH ANGIOMAX THE ENDOMAX TRIAL,NA,400
The Medicines Company,2016-02-10,Cash or cash equivalent,ENDOVASCULAR INTERVENTIONS WITH ANGIOMAX THE ENDOMAX TRIAL,NA,400
Valeant Pharmaceuticals North America LLC,2016-02-10,Cash or cash equivalent,A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER,211357,185
Cook Research Incorporated,2016-02-11,Cash or cash equivalent,Evolution Biliary Fully Covered (Malignant),806291,380
Cook Research Incorporated,2016-02-11,Cash or cash equivalent,Zenith Transection,192614,150
Cook Research Incorporated,2016-02-11,Cash or cash equivalent,NA,NA,300
"E.R. Squibb & Sons, L.L.C.",2016-02-12,Cash or cash equivalent,Phase II Sequential Ipi Anti PD 1,157351,15618.99
"Genentech, Inc.",2016-02-15,Cash or cash equivalent,A PHASE III TRIAL IN ADJUVANT HER2 BC PTS,760719,6750
"AbbVie, Inc.",2016-02-16,Cash or cash equivalent,M14-011,596090,8697.27
Boston Scientific Corporation,2016-02-16,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,306.25
Cook Research Incorporated,2016-02-16,Cash or cash equivalent,NA,NA,3700
Emergent Biosolutions Inc.,2016-02-16,Cash or cash equivalent,RSDL,824482,4e3
Pfizer Inc.,2016-02-16,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,35215
Cook Research Incorporated,2016-02-18,Cash or cash equivalent,Zenith Dissection Endovascular System pivotal stud,124369,550
"Genentech, Inc.",2016-02-19,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,8293.25
"Zimmer Biomet Holdings, Inc.",2016-02-19,Cash or cash equivalent,MarrowStim PAD Kit Study,570554,6250
DePuy Orthopaedics Inc.,2016-02-23,Cash or cash equivalent,Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity.,147144,907.5
Pfizer Inc.,2016-02-23,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,56396.31
AstraZeneca Pharmaceuticals LP,2016-02-24,Cash or cash equivalent,Randomised double blind parallel group multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death myocardial infarction and ischaemic stroke in patients with established Peripheral Artery Disease EUCLID Examining Use of tiCagreLor In paD,82765,10802.5
Biotest Pharmaceuticals Corporation,2016-02-24,Cash or cash equivalent,HCIG to prevent Hep C recurrence in Liver transplant,NA,4800
SANOFI US SERVICES INC.,2016-02-24,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,2130
"Seattle Genetics, Inc.",2016-02-24,Cash or cash equivalent,SG0350014,366054,4745.5
"MicroVention, Inc.",2016-02-26,Cash or cash equivalent,HEAT,355275,1092
"AbbVie, Inc.",2016-02-29,Cash or cash equivalent,M13-740,594186,21795.75
Allergan Inc.,2016-02-29,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,28414.5
"Carestream Health, Inc.",2016-03-01,Cash or cash equivalent,Vue search software,NA,83333
Kadmon Corporation LLC,2016-03-01,In-kind items and services,Long Term Treatment and Follow up of Subjects Completing 24 Months of Treatment with Tesevatinib on Study KD019 101 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,1769.7
"E.R. Squibb & Sons, L.L.C.",2016-03-02,Cash or cash equivalent,Evaluating Nulojix Belatacept Long Term Safety in Transplant ENLIST,696729,3325
AstraZeneca Pharmaceuticals LP,2016-03-03,Cash or cash equivalent,NA,696192,1787115
Novartis Pharmaceuticals Corporation,2016-03-03,Cash or cash equivalent,A LONG TERM MULTICENTER NON INTERVENTIONAL OBSERVATIONAL STUDY MONITORING LONG TERM SAFETY AND EFFECTIVENESS OF GILENYATM FINGOLIMOD HALF OF A MG IN PATIENTS WITH MULTIPLE SCLEROSIS WHO HAVE PARTICIPATED IN THE FINGOLIMOD CLINICAL DEVELOPMENT PROGRAM,74842,4500
"Zimmer Biomet Holdings, Inc.",2016-03-03,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,7781
"Zimmer Biomet Holdings, Inc.",2016-03-03,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,7781
Abbott Laboratories,2016-03-04,Cash or cash equivalent,EVEREST II,217198,1417.5
"InSightec,LTD",2016-03-05,Cash or cash equivalent,A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects,NA,91029
Allergan Inc.,2016-03-07,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,3743
Boston Scientific Corporation,2016-03-07,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,1545
Celgene Corporation,2016-03-07,Cash or cash equivalent,ABI-007-PANC-003,875821,19141.56
Terumo Medical Corporation,2016-03-08,Cash or cash equivalent,OSPREY SFA,300280,3e3
"Siemens Medical Solutions USA, Inc.",2016-03-09,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,75.6
Purdue Pharma,2016-03-10,Cash or cash equivalent,063-013,NA,14591.17
"Actelion Pharmaceuticals US, Inc.",2016-03-11,Cash or cash equivalent,QUERI ACHD - AC-052433 USA,475119,200
"InSightec,Inc",2016-03-11,Cash or cash equivalent,PD003,549431,7800
"Janssen Research & Development, LLC",2016-03-11,Cash or cash equivalent,"An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban versus Dose-Adjusted Oral Vitamin K Antagonist in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)",601536,3189
Cook Research Incorporated,2016-03-15,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,294839,250
GENZYME CORPORATION,2016-03-15,Cash or cash equivalent,data entry registry Pompe LSD,NA,150
GENZYME CORPORATION,2016-03-15,Cash or cash equivalent,data entry registry MPS1 LSD,NA,850
GENZYME CORPORATION,2016-03-15,Cash or cash equivalent,data entry registry Gaucher LSD,NA,200
GENZYME CORPORATION,2016-03-15,Cash or cash equivalent,data entry registry Fabry LSD,NA,925
Celgene Corporation,2016-03-16,Cash or cash equivalent,CC-5013-MCL-001,57874,1508
"NEUROPACE, INC.",2016-03-16,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,1175
"Siemens Medical Solutions USA, Inc.",2016-03-16,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,8150
"Teva Pharmaceuticals USA, Inc.",2016-03-16,Cash or cash equivalent,C18083/3064/NL/MN,535876,980
"AbbVie, Inc.",2016-03-21,Cash or cash equivalent,M14-011,596090,10801.86
"Genentech, Inc.",2016-03-21,Cash or cash equivalent,AVENUE,250079,7892
"Otsuka Pharmaceutical Development & Commercialization, Inc.",2016-03-21,Cash or cash equivalent,OPEN-LABEL TRIAL TO EVALUATE THE LONG TERM SAFETY OF TITRATED IMMEDIATE-RELEASE TOLVAPTAN IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE,279373,12133.11
Cook Research Incorporated,2016-03-23,Cash or cash equivalent,NA,NA,6676.01
"Siemens Medical Solutions USA, Inc.",2016-03-23,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,8150
Terumo Medical Corporation,2016-03-24,Cash or cash equivalent,OSPREY SFA,300280,6200
Daiichi Sankyo Company LTD,2016-03-25,Cash or cash equivalent,NA,594334,5e5
"Genentech, Inc.",2016-03-25,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,3240
"AbbVie, Inc.",2016-03-28,Cash or cash equivalent,M14-360,1194702,3998.75
NOVARTIS PHARMACEUTICALS CORPORATION,2016-03-28,Cash or cash equivalent,A phase II study of ofatumumab based induction chemoimmunotherapy followed by consolidation ofatumumab immunotherapy in previously untreated patients with chronic lymphocytic leukemia small lymphocytic lymphoma,NA,606.02
NOVARTIS PHARMACEUTICALS CORPORATION,2016-03-28,Cash or cash equivalent,A phase II study of ofatumumab based induction chemoimmunotherapy followed by consolidation ofatumumab immunotherapy in previously untreated patients with chronic lymphocytic leukemia small lymphocytic lymphoma,NA,2e4
NOVARTIS PHARMACEUTICALS CORPORATION,2016-03-28,Cash or cash equivalent,A phase II study of ofatumumab based induction chemoimmunotherapy followed by consolidation ofatumumab immunotherapy in previously untreated patients with chronic lymphocytic leukemia small lymphocytic lymphoma,NA,2e4
SANOFI US SERVICES INC.,2016-03-28,Cash or cash equivalent,ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727),NA,137.14
Novo Nordisk AS,2016-03-29,Cash or cash equivalent,NN7008-3809,500528,1419.2
Pfizer Inc.,2016-03-29,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,48936.92
"Zimmer Biomet Holdings, Inc.",2016-03-29,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,6375
"InSightec,LTD",2016-03-30,Cash or cash equivalent,Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Risk Prostate Cancer,195111,15625
SANOFI US SERVICES INC.,2016-03-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,4380
CorMatrix Cardiovascular Inc.,2016-03-31,Cash or cash equivalent,Carotid Registry,188640,1428.75
Abbott Laboratories,2016-04-01,Cash or cash equivalent,EVEREST II,217198,1282.5
"E.R. Squibb & Sons, L.L.C.",2016-04-01,Cash or cash equivalent,Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix Belatacept Based Immunosuppression,696729,90413.71
Boston Scientific Corporation,2016-04-04,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,2945
Eli Lilly and Company,2016-04-04,Cash or cash equivalent,ASSESSMENT OF CLINICAL EFFECTS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITION WITH EVACETRAPIB IN PATIENTS AT A HIGH RISK FOR VASCULAR OUTCOMES,1043167,1466
"MicroVention, Inc.",2016-04-04,Cash or cash equivalent,HEAT,355275,693
BIOTRONIK INC.,2016-04-06,Cash or cash equivalent,BIOFLOW-V,601536,42995.59
Purdue Pharma,2016-04-07,Cash or cash equivalent,063-013,NA,80266.25
"E.R. Squibb & Sons, L.L.C.",2016-04-08,Cash or cash equivalent,Phase III Adjuvant Melanoma,812566,96792.62
"AbbVie, Inc.",2016-04-11,Cash or cash equivalent,M14-360,1194702,5900
Elekta Instrument AB,2016-04-11,Cash or cash equivalent,Dose distortions due to embolic agents,NA,3e4
Pfizer Inc.,2016-04-12,Cash or cash equivalent,Study Of The Blood Thinner Apixaban For Patients Who Have An Abnormal Heart Rhythm Atrial Fibrillation And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm Cardioversion,198456,937.5
"AbbVie, Inc.",2016-04-13,Cash or cash equivalent,M13-740,594186,5467.5
"Siemens Medical Solutions USA, Inc.",2016-04-13,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,75.6
"Siemens Medical Solutions USA, Inc.",2016-04-13,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,18741.5
"St. Jude Medical, Inc.",2016-04-13,Cash or cash equivalent,ADVANCE ASO,217198,10805.25
"Zimmer Biomet Holdings, Inc.",2016-04-14,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,7781
"W. L. Gore & Associates, Inc.",2016-04-15,Cash or cash equivalent,GORE HELEX  Septal Occluder  GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging Confirmed TIA in Patients with Patent Foramen Ovale PFO,220413,3125
Boston Scientific Corporation,2016-04-18,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,170
Boston Scientific Corporation,2016-04-18,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,1880
"Genentech, Inc.",2016-04-18,Cash or cash equivalent,A PHASE III TRIAL IN ADJUVANT HER2 BC PTS,760719,2250
"Rivanna Medical, LLC",2016-04-18,Cash or cash equivalent,MD-ANES Low-Cost Handheld Medical Device for Neuroaxial Anesthesia Guidance in the Obese,NA,68437
SANOFI US SERVICES INC.,2016-04-18,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,700
Pfizer Inc.,2016-04-19,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,22100
"Alkermes, Inc.",2016-04-20,Cash or cash equivalent,"A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder",373291,2515
"Alkermes, Inc.",2016-04-20,Cash or cash equivalent,"A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder",373291,3525
F. Hoffmann-La Roche AG,2016-04-20,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,12152.75
Edwards Lifesciences Corporation,2016-04-22,Cash or cash equivalent,The PARTNER Trial Placement of Aortic Transcatheter Valve Trial 2006-06,217198,2400
Edwards Lifesciences Corporation,2016-04-22,Cash or cash equivalent,The PARTNER II Trial Placement of Aortic Transcatheter Valve Trial 2010-12,123007,14400
Edwards Lifesciences Corporation,2016-04-22,Cash or cash equivalent,The PARTNER II Trial Placement of Aortic Transcatheter Valve Trial 2010-12,123007,71e3
The Medicines Company,2016-04-22,Cash or cash equivalent,ENDOVASCULAR INTERVENTIONS WITH ANGIOMAX THE ENDOMAX TRIAL,NA,250
Allergan Inc.,2016-04-25,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,250
Allergan Inc.,2016-04-25,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,125
Allergan Inc.,2016-04-25,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,5
Allergan Inc.,2016-04-25,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,36
Allergan Inc.,2016-04-25,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,47
Allergan Inc.,2016-04-25,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,125
"Genentech, Inc.",2016-04-25,Cash or cash equivalent,A PHASE III TRIAL IN ADJUVANT HER2 BC PTS,760719,15228
Novo Nordisk AS,2016-04-26,Cash or cash equivalent,NN7008-3809,500528,1748
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,75
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,33
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,5
Allergan Inc.,2016-04-27,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,30
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,33
Allergan Inc.,2016-04-27,Cash or cash equivalent,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,20
Allergan Inc.,2016-04-27,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-04-27,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,33
"Seattle Genetics, Inc.",2016-04-27,Cash or cash equivalent,SG0350014,366054,3275
"CardioFocus, Inc.",2016-04-28,Cash or cash equivalent,Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact,281489,5937.5
"Abbvie, Inc.",2016-04-29,In-kind items and services,CU-01,366054,390.39
"Abbvie, Inc.",2016-04-29,In-kind items and services,CU-01,366054,39511.36
"Abbvie, Inc.",2016-04-29,In-kind items and services,CU-01,366054,1672.86
"AbbVie, Inc.",2016-05-02,Cash or cash equivalent,M14-360,1194702,8147.5
Allergan Inc.,2016-05-02,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,4555.25
"Takeda Development Center Americas, Inc.",2016-05-02,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder",316643,668.75
"AbbVie, Inc.",2016-05-05,Cash or cash equivalent,M14-360,1194702,2375
"Actelion Pharmaceuticals US, Inc.",2016-05-06,Cash or cash equivalent,OPUS - AC-055-503,199176,1200
F. Hoffmann-La Roche AG,2016-05-09,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,1963.73
F. Hoffmann-La Roche AG,2016-05-09,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,2096.81
"AbbVie, Inc.",2016-05-11,Cash or cash equivalent,M13-740,594186,3574.25
Cook Research Incorporated,2016-05-11,Cash or cash equivalent,Zenith Dissection Endovascular System pivotal stud,124369,1050
Cook Research Incorporated,2016-05-11,Cash or cash equivalent,Evolution Biliary Fully Covered (Malignant),806291,480
Cook Research Incorporated,2016-05-11,Cash or cash equivalent,NA,NA,1050
"Zimmer Biomet Holdings, Inc.",2016-05-11,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,8937.5
"CardioFocus, Inc.",2016-05-12,Cash or cash equivalent,Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact,281489,3562
Boston Scientific Corporation,2016-05-13,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,4171.28
"Genentech, Inc.",2016-05-13,Cash or cash equivalent,APDL1 BLADDER EAP,266016,12606.3
Allergan Inc.,2016-05-16,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,3904.5
Novartis Pharmaceuticals Corporation,2016-05-16,Cash or cash equivalent,A SINGLE ARM OPEN LABEL MULTICENTER STUDY EVALUATING THE LONG TERM SAFETY AND TOLERABILITY OF HALF OF A MG FINGOLIMOD FTY720 ADMINISTERED ORALLY ONCE DAILY IN PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS,74842,181961.09
"Abbvie, Inc.",2016-05-17,In-kind items and services,CU-01,366054,438.13
"Genentech, Inc.",2016-05-17,Cash or cash equivalent,PRISMS,NA,2e3
Purdue Pharma,2016-05-17,Cash or cash equivalent,063-013,NA,172530
Edwards Lifesciences Corporation,2016-05-18,Cash or cash equivalent,Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction COMPASSION S3,217198,16250
"Siemens Medical Solutions USA, Inc.",2016-05-18,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,20550
"Siemens Medical Solutions USA, Inc.",2016-05-18,Cash or cash equivalent,UVA Haskal AX 2015 Body,99365,16199.5
Valeant Pharmaceuticals North America LLC,2016-05-19,Cash or cash equivalent,A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER,211357,1649
"Actelion Pharmaceuticals, Ltd",2016-05-20,Cash or cash equivalent,AC-055-205,199176,5300
"Actelion Pharmaceuticals, Ltd",2016-05-20,Cash or cash equivalent,AC-055-205,199176,2e3
"Actelion Pharmaceuticals, Ltd",2016-05-20,Cash or cash equivalent,AC-055-205,199176,2500
Pfizer Inc.,2016-05-23,Cash or cash equivalent,Sertraline Pediatric Registry for the Evaluation of Safety SPRITES,81927,625
"Ceterix Orthopaedics, Inc.",2016-05-24,Cash or cash equivalent,Comparative Study of the Ceterix Suture Pattern vs. the FastFix 360 for Meniscus Tears,955960,9165
"Genentech, Inc.",2016-05-24,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,24532.5
SANOFI US SERVICES INC.,2016-05-25,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,1705
SANOFI US SERVICES INC.,2016-05-25,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,12.54
"Siemens Medical Solutions USA, Inc.",2016-05-25,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,151.2
Novo Nordisk AS,2016-05-26,Cash or cash equivalent,NN7008-3809,500528,1445.6
Sorin Group USA Inc.,2016-05-26,Cash or cash equivalent,Mitroflow,188640,4650
Eli Lilly and Company,2016-05-27,In-kind items and services,A PHASE II STUDY OF THE COMBINATION OF LY3023414 AND NECITUMUMAB AFTER FIRST-LINE CHEMOTHERAPY FOR METASTATIC SQUAMOUS NON-SMALL CELL CARCINOMA OF THE LUNG,808737,604.82
"AbbVie, Inc.",2016-06-06,Cash or cash equivalent,M14-011,596090,10380.73
Abbott Laboratories,2016-06-07,Cash or cash equivalent,EVEREST II,217198,945
"AbbVie, Inc.",2016-06-08,Cash or cash equivalent,M14-011,596090,57226.39
"Zimmer Biomet Holdings, Inc.",2016-06-08,Cash or cash equivalent,MarrowStim PAD Kit Study,570554,325
Sorin Group USA Inc.,2016-06-09,Cash or cash equivalent,Perceval,213301,11650
"Alexion Pharmaceuticals, Inc.",2016-06-10,Cash or cash equivalent,Atypcial Hemolytic-Uremic Syndrome aHUS Registry,244226,375
Cook Research Incorporated,2016-06-10,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,294839,50
Cook Research Incorporated,2016-06-10,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,294839,600
"Pharmacyclics LLC, An AbbVie Company",2016-06-10,Cash or cash equivalent,PCYC-1112-CA,744701,1935.71
"Pharmacyclics LLC, An AbbVie Company",2016-06-10,Cash or cash equivalent,PCYC-1112-CA,744701,18997.5
Allergan Inc.,2016-06-13,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,250
Allergan Inc.,2016-06-13,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,125
Allergan Inc.,2016-06-13,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,47
Allergan Inc.,2016-06-13,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,125
Allergan Inc.,2016-06-13,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,36
Allergan Inc.,2016-06-13,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,5
"Genentech, Inc.",2016-06-14,Cash or cash equivalent,PRISMS,NA,250
Allergan Inc.,2016-06-15,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,105
Allergan Inc.,2016-06-15,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,30
"E.R. Squibb & Sons, L.L.C.",2016-06-15,Cash or cash equivalent,Evaluation of Acute Rejection Rates in de Novo Renal Transplant Recipients Following Thymoglobulin Induction CNI free Nulojix Belatacept Based Immunosuppression,696729,8e3
Pfizer Inc.,2016-06-15,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,51088.89
SANOFI US SERVICES INC.,2016-06-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,600
HOLOGIC INC,2016-06-16,Cash or cash equivalent,Evaluation of Mammography Compression,NA,42207.67
Purdue Pharma,2016-06-16,Cash or cash equivalent,063-013,NA,215051.25
Cook Research Incorporated,2016-06-17,Cash or cash equivalent,NA,NA,10974.77
Cook Research Incorporated,2016-06-17,Cash or cash equivalent,NA,NA,15619
"W. L. Gore & Associates, Inc.",2016-06-17,Cash or cash equivalent,GORE HELEX  Septal Occluder  GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging Confirmed TIA in Patients with Patent Foramen Ovale PFO,220413,562.5
Boston Scientific Corporation,2016-06-20,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,2705
Boston Scientific Corporation,2016-06-20,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,1562.5
DePuy Orthopaedics Inc.,2016-06-20,Cash or cash equivalent,Multi-Center Prospective Evaluation of Operative vs Non-operative for ASD,147144,600
"E.R. Squibb & Sons, L.L.C.",2016-06-20,Cash or cash equivalent,Phase III GBM 2L registrational,528783,3850
Vertex Pharmaceuticals Incorporated,2016-06-20,Cash or cash equivalent,Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor,826949,38788.86
GENZYME CORPORATION,2016-06-21,Cash or cash equivalent,Q1 2016 Fabry LSD Registry,NA,650
GENZYME CORPORATION,2016-06-21,Cash or cash equivalent,Q1 2016 Gaucher LSD Registry,NA,600
"W. L. Gore & Associates, Inc.",2016-06-21,Cash or cash equivalent,GORE Septal Occluder Clinical Study A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects ASDs,217198,6062.5
"Actelion Pharmaceuticals US, Inc.",2016-06-22,Cash or cash equivalent,QUERI ACHD - AC-052433 USA,475119,400
"Genentech, Inc.",2016-06-22,Cash or cash equivalent,AVENUE,250079,12369
"Millennium Pharmaceuticals, Inc.",2016-06-22,Cash or cash equivalent,"MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer",945020,11464
Celgene Corporation,2016-06-24,Cash or cash equivalent,ABI-007-PANC-003,266016,12021.04
Corindus Inc.,2016-06-24,Cash or cash equivalent,PRECISION Registry Protocol,601536,16250
"Genentech, Inc.",2016-06-24,Cash or cash equivalent,APDL1 BLADDER EAP,266016,3475
SANOFI US SERVICES INC.,2016-06-27,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,12.54
CorMatrix Cardiovascular Inc.,2016-06-29,Cash or cash equivalent,Perform,312047,6350
Edwards Lifesciences Corporation,2016-06-29,In-kind items and services,Compassion S3 2015-01,96907,6718.05
"NEUROPACE, INC.",2016-06-29,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,462.5
"Penumbra, Inc.",2016-06-29,Cash or cash equivalent,A prospective multicenter registry assessing the embolization of neurovascular lesions using the  Penumbra SMART COIL System,329114,1e4
Pfizer Inc.,2016-06-29,Cash or cash equivalent,NA,NA,81658
CorMatrix Cardiovascular Inc.,2016-06-30,Cash or cash equivalent,Carotid Registry,188640,571.5
"Aesculap Biologics, LLC",2016-07-01,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartiage of the Knee N3D,243965,46789
Allergan Inc.,2016-07-01,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,5
"AbbVie, Inc.",2016-07-06,Cash or cash equivalent,M14-360,1194702,3427.5
DePuy Orthopaedics Inc.,2016-07-12,Cash or cash equivalent,Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity.,147144,858.75
"Lutonix, Inc.",2016-07-12,Cash or cash equivalent,LTX AV,296287,3750
"W. L. Gore & Associates, Inc.",2016-07-12,Cash or cash equivalent,Gore Research and Development,NA,1500
BIOTRONIK INC.,2016-07-13,Cash or cash equivalent,BIOFLOW-V,601536,16053.22
F. Hoffmann-La Roche AG,2016-07-13,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,2525
F. Hoffmann-La Roche AG,2016-07-13,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,2496.9
F. Hoffmann-La Roche AG,2016-07-13,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,17012.43
Gilead Sciences Inc,2016-07-13,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,575
"St. Jude Medical, Inc.",2016-07-13,Cash or cash equivalent,VPA,217198,875
"AbbVie, Inc.",2016-07-14,Cash or cash equivalent,M14-011,596090,10764.36
"Actelion Pharmaceuticals US, Inc.",2016-07-15,Cash or cash equivalent,OPUS - AC-055-503,199176,1200
AstraZeneca Pharmaceuticals LP,2016-07-18,Cash or cash equivalent,Randomized Placebo-controlled single Blind Trial to determine the Safety and Efficacy of Ticagrelor for Maintaining  Patency of Arterio-Venous Fistulae Created for Hemodialysis,368063,23800
Boston Scientific Corporation,2016-07-18,Cash or cash equivalent,CAP2 - PREVAIL CONTINUED ACCESS REGISTRY,217198,1375
Boston Scientific Corporation,2016-07-18,Cash or cash equivalent,CAP2 - PREVAIL CONTINUED ACCESS REGISTRY,217198,562.5
F. Hoffmann-La Roche AG,2016-07-18,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,26824.56
Pfizer Inc.,2016-07-18,Cash or cash equivalent,NA,257796,12500
Purdue Pharma,2016-07-19,Cash or cash equivalent,063-013,NA,472518.99
"W. L. Gore & Associates, Inc.",2016-07-19,Cash or cash equivalent,Gore Research and Development,NA,19487.5
"AbbVie, Inc.",2016-07-20,Cash or cash equivalent,M13-740,594186,7789.94
Allergan Inc.,2016-07-20,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,7201
Allergan Inc.,2016-07-20,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,3329.75
Allergan Inc.,2016-07-20,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,3624.25
Edwards Lifesciences Corporation,2016-07-20,Cash or cash equivalent,The PARTNER II Trial Placement of Aortic Transcatheter Valve Trial 2010-12,123007,13700
F. Hoffmann-La Roche AG,2016-07-20,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,27467.86
"St. Jude Medical, Inc.",2016-07-20,Cash or cash equivalent,ADVANCE ASO,217198,14311.5
"Alexion Pharmaceuticals, Inc.",2016-07-21,Cash or cash equivalent,Atypcial Hemolytic-Uremic Syndrome aHUS Registry,244226,375
"Genentech, Inc.",2016-07-21,Cash or cash equivalent,A PHASE III TRIAL IN ADJUVANT HER2 BC PTS,760719,4542.34
"Pharmacyclics LLC, An AbbVie Company",2016-07-21,Cash or cash equivalent,PCYC-1112-CA,744701,701.57
Edwards Lifesciences Corporation,2016-07-22,Cash or cash equivalent,The PARTNER Trial Placement of Aortic Transcatheter Valve Trial 2006-06,217198,3800
Abbott Laboratories,2016-07-26,Cash or cash equivalent,COAPT,217198,11200
"AbbVie, Inc.",2016-07-26,Cash or cash equivalent,P12-792,826949,230.61
"Genentech, Inc.",2016-07-26,Cash or cash equivalent,APDL1 PHASE II IN PD L1 POSITIVE NSCLC PTS,808737,882.23
Incyte Corporation,2016-07-26,Cash or cash equivalent,"A Phase II Pilot Trial of an Indoleamine 2, 3, dioxygenase 1 IDO1 InhibitorINCB024360 Plus a Multipeptide Melanoma Vaccine MELITAC 12.1 in Patients with Advanced Melanoma",157351,1162.8
Allergan Inc.,2016-07-27,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,93.75
Allergan Inc.,2016-07-27,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,58.75
Allergan Inc.,2016-07-27,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,180
Allergan Inc.,2016-07-27,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,156.25
Allergan Inc.,2016-07-27,In-kind items and services,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",322890,156.25
Eli Lilly and Company,2016-07-27,Cash or cash equivalent,A PHASE II STUDY OF THE COMBINATION OF LY3023414 AND NECITUMUMAB AFTER FIRST-LINE CHEMOTHERAPY FOR METASTATIC SQUAMOUS NON-SMALL CELL CARCINOMA OF THE LUNG,808737,9877
"Genentech, Inc.",2016-07-27,Cash or cash equivalent,AVENUE,250079,3e3
Gilead Sciences Inc,2016-07-27,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,7663
SANOFI US SERVICES INC.,2016-07-27,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,1700
Biocompatibles UK Ltd,2016-07-28,Cash or cash equivalent,QYF0001 TS 102 EPOCH,48856,1350
"AbbVie, Inc.",2016-08-01,Cash or cash equivalent,M13-740,594186,5600
F. Hoffmann-La Roche AG,2016-08-01,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,35938.16
Novo Nordisk Inc,2016-08-01,Cash or cash equivalent,HGH-2149 ANSWER Study,305055,600
"Roche Diagnostics Operations, Inc.",2016-08-01,In-kind items and services,RD002446,408254,2490.42
Kadmon Corporation LLC,2016-08-02,Cash or cash equivalent,Long Term Treatment and Follow up of Subjects Completing 24 Months of Treatment with Tesevatinib on Study KD019 101 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,13889.38
Pfizer Inc.,2016-08-02,Cash or cash equivalent,A Phase 2b Randomized Doubleblind Placebocontrolled Study To Evaluate The Safety And Efficacy Of Staphylococcus Aureus 4antigen Vaccine sa4ag In Adults Undergoing Elective Posterior Instrumented Lumbar Spinal Fusion Procedures,31776,7280
"Siemens Medical Solutions USA, Inc.",2016-08-02,Cash or cash equivalent,D-Dimer DVT/PE Exclusionary Sample Collection Project.,228567,17942.4
"Medtronic USA, Inc.",2016-08-03,In-kind items and services,SANTE,164924,2390
Novartis Pharmaceuticals Corporation,2016-08-03,Cash or cash equivalent,PHASE 1B STUDY TO ASSESS TUMOR PHARMACOKINETICS PHARMACODYNAMICS AND EFFICACY OF THE CDK4 AND OR 6 INHIBITOR LEE011 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR ANAPLASTIC ASTROCYTOMA,1152902,58641.75
Boston Scientific Corporation,2016-08-04,Cash or cash equivalent,BRONCHIAL THERMOPLASTY IN SEVERE PERSISTENT ASTHMA (PAS2),945724,250
Gilead Sciences Inc,2016-08-05,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,11500
"Takeda Development Center Americas, Inc.",2016-08-05,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder",316643,9298.8
"AbbVie, Inc.",2016-08-08,Cash or cash equivalent,M14-360,1194702,4648.75
Allergan Inc.,2016-08-08,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,44
Allergan Inc.,2016-08-08,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,30
Allergan Inc.,2016-08-08,In-kind items and services,"A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER",322890,87.5
Allergan Inc.,2016-08-08,In-kind items and services,"A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER",322890,55
Allergan Inc.,2016-08-08,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,10
Allergan Inc.,2016-08-08,In-kind items and services,"AN OPEN LABEL, LONG-TERM STUDY TO ASSESS THE IMMUNOGENICITY OF LINACLOTIDE ADMINISTERED ORALLY TO ADULT PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION OR CHRONIC IDIOPATHIC CONSTIPATION",322890,20
Allergan Inc.,2016-08-08,In-kind items and services,"A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER",322890,145.5
Purdue Pharma,2016-08-09,Cash or cash equivalent,063-013,NA,15081.25
"Seattle Genetics, Inc.",2016-08-10,Cash or cash equivalent,SG019A0003,366054,15125
Sorin Group USA Inc.,2016-08-10,Cash or cash equivalent,Perceval,213301,15225
Valeant Pharmaceuticals North America LLC,2016-08-15,Cash or cash equivalent,A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER,211357,185
"Genentech, Inc.",2016-08-16,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,11197.5
"AbbVie, Inc.",2016-08-22,Cash or cash equivalent,M13-740,594186,23716.25
Cook Research Incorporated,2016-08-22,Cash or cash equivalent,Evolution Biliary Fully Covered (Malignant),806291,140
Cook Research Incorporated,2016-08-22,Cash or cash equivalent,Zenith Transection,192614,275
Pfizer Inc.,2016-08-22,Cash or cash equivalent,Differential effects of CEE and estradiol on benign and malignant breast Rationale why CEEBZA is most effective TSEC,335990,6e4
Cook Research Incorporated,2016-08-23,Cash or cash equivalent,Zenith Dissection Endovascular System pivotal stud,124369,300
Purdue Pharma,2016-08-23,Cash or cash equivalent,063-013,NA,55582.5
"Genentech, Inc.",2016-08-24,Cash or cash equivalent,AVENUE,250079,3759
Gilead Sciences Inc,2016-08-24,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,1294
SANOFI US SERVICES INC.,2016-08-24,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,1e3
"Siemens Medical Solutions USA, Inc.",2016-08-24,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,4200
"Siemens Medical Solutions USA, Inc.",2016-08-24,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,9850
"Zimmer Biomet Holdings, Inc.",2016-08-25,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,2437.5
Abbott Laboratories,2016-08-29,Cash or cash equivalent,EVEREST II,217198,8910
"Takeda Development Center Americas, Inc.",2016-08-29,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder",316643,2069.1
"Seattle Genetics, Inc.",2016-08-30,Cash or cash equivalent,SG019A0003,366054,25268.37
Allergan Inc.,2016-08-31,Cash or cash equivalent,"A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER MDD",322890,369.45
"Roche Diagnostics Operations, Inc.",2016-09-01,In-kind items and services,RD002446,408254,332.44
"Genentech, Inc.",2016-09-02,Cash or cash equivalent,APDL1 BLADDER EAP,266016,18125.1
"AbbVie, Inc.",2016-09-06,Cash or cash equivalent,M14-011,596090,1406.5
GENZYME CORPORATION,2016-09-06,Cash or cash equivalent,Q2 2016 Gaucher LSD Registry,NA,1650
GENZYME CORPORATION,2016-09-06,Cash or cash equivalent,Q2 2016 Fabry LSD Registry,NA,2450
GENZYME CORPORATION,2016-09-06,Cash or cash equivalent,Q2 2016 MPS1 LSD Registry,NA,925
GENZYME CORPORATION,2016-09-06,Cash or cash equivalent,Q2 2016 Pompe LSD Registry,NA,1775
"InSightec,LTD",2016-09-06,Cash or cash equivalent,Long term  follow up to collect data following  MR-Guided Focused Ultrasound Treatment of Uterine Fibroids with ExAblate Model 2100 Type 1.1 System,147662,22747.5
Allergan Inc.,2016-09-08,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,3144.5
Edwards Lifesciences Corporation,2016-09-08,In-kind items and services,Compassion S3 2015-01,96907,12333.4
DePuy Orthopaedics Inc.,2016-09-09,Cash or cash equivalent,Multi-Center Prospective Evaluation of Operative vs Non-operative for ASD,147144,200
"AbbVie, Inc.",2016-09-14,Cash or cash equivalent,M13-740,594186,3930.5
Cook Research Incorporated,2016-09-16,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,294839,700
Cook Research Incorporated,2016-09-16,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,294839,50
"Genentech, Inc.",2016-09-19,Cash or cash equivalent,AVENUE,250079,41348
Pfizer Inc.,2016-09-19,Cash or cash equivalent,Differential effects of CEE and estradiol on benign and malignant breast Rationale why CEEBZA is most effective TSEC,335990,25e3
Cook Research Incorporated,2016-09-20,Cash or cash equivalent,NA,NA,23013
Cook Research Incorporated,2016-09-20,Cash or cash equivalent,NA,NA,12726.15
"Exactech, Inc.",2016-09-22,Cash or cash equivalent,A Prospective Multi-center Data Collection to Assess the Exactech Guided Personalized Surgery eGPS in Total Knee Arthroplasty,233499,9375
Gilead Sciences Inc,2016-09-23,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,2741
"W. L. Gore & Associates, Inc.",2016-09-23,Cash or cash equivalent,GORE HELEX  Septal Occluder  GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging Confirmed TIA in Patients with Patent Foramen Ovale PFO,220413,3375
"W. L. Gore & Associates, Inc.",2016-09-23,Cash or cash equivalent,Gore Research and Development,NA,6787.5
Purdue Pharma,2016-09-27,Cash or cash equivalent,063-013,NA,14905.14
"E.R. Squibb & Sons, L.L.C.",2016-09-28,Cash or cash equivalent,Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix Belatacept Based Immunosuppression,696729,72969.1
SANOFI US SERVICES INC.,2016-09-28,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,600
"Aesculap Biologics, LLC",2016-09-30,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartiage of the Knee N3D,243965,985.05
CorMatrix Cardiovascular Inc.,2016-09-30,Cash or cash equivalent,Carotid Registry,188640,254
Abbott Laboratories,2016-10-03,Cash or cash equivalent,Evaluation of XIENCE PRIME Everolimus Eluting Stent System EECSS or XIENCE V EECSS or XIENCE Xpedition EECSS or XIENCE PRO EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization,601536,2467
"AbbVie, Inc.",2016-10-03,Cash or cash equivalent,M14-360,1194702,1366.25
Abbott Laboratories,2016-10-04,Cash or cash equivalent,Evaluation of XIENCE PRIME Everolimus Eluting Stent System EECSS or XIENCE V EECSS or XIENCE Xpedition EECSS or XIENCE PRO EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization,601536,5500
Abbott Laboratories,2016-10-05,Cash or cash equivalent,Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation,217198,13550
"E.R. Squibb & Sons, L.L.C.",2016-10-05,Cash or cash equivalent,Evaluation of Acute Rejection Rates in de Novo Renal Transplant Recipients Following Thymoglobulin Induction CNI free Nulojix Belatacept Based Immunosuppression,696729,10870
"Genentech, Inc.",2016-10-07,Cash or cash equivalent,APDL1 BLADDER EAP,266016,10638
"MicroVention, Inc.",2016-10-07,Cash or cash equivalent,HEAT,355275,6237
"W. L. Gore & Associates, Inc.",2016-10-07,Cash or cash equivalent,GORE Septal Occluder Clinical Study A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects ASDs,217198,2687.5
"Varian Medical Systems, Inc.",2016-10-10,Cash or cash equivalent,Real-time delivery with EPID -U.V.,NA,7e4
"AbbVie, Inc.",2016-10-11,Cash or cash equivalent,M14-011,596090,3544.43
Boston Scientific Corporation,2016-10-11,Cash or cash equivalent,BRONCHIAL THERMOPLASTY IN SEVERE PERSISTENT ASTHMA (PAS2),945724,600
Eli Lilly and Company,2016-10-11,Cash or cash equivalent,"A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED PHASE II STUDY OF ENZALUTAMIDE WITH OR WITHOUT THE PI3 KINASE-MTOR INHIBITOR LY3023414 IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER",266016,4933
Novo Nordisk AS,2016-10-11,In-kind items and services,NN2211-3659,684755,542.09
Pfizer Inc.,2016-10-11,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,61218.98
Purdue Pharma,2016-10-11,Cash or cash equivalent,063-013,NA,646.17
"Abbvie, Inc.",2016-10-12,In-kind items and services,CU-01,129137,49389.2
Edwards Lifesciences Corporation,2016-10-12,Cash or cash equivalent,The PARTNER Trial Placement of Aortic Transcatheter Valve Trial 2006-06,92091,1200
Exelixis Inc.,2016-10-12,Cash or cash equivalent,NA,NA,3e4
"Genentech, Inc.",2016-10-12,Cash or cash equivalent,A PHASE III TRIAL IN ADJUVANT HER2 BC PTS,760719,480.5
"St. Jude Medical, Inc.",2016-10-12,Cash or cash equivalent,ADVANCE ASO,217198,17016.75
"Roche Diagnostics Operations, Inc.",2016-10-13,Cash or cash equivalent,RD002446,408254,11297.5
"Aesculap Biologics, LLC",2016-10-14,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartiage of the Knee N3D,243965,32231
"Seattle Genetics, Inc.",2016-10-14,Cash or cash equivalent,SG019A0003,366054,13319.96
"AbbVie, Inc.",2016-10-17,Cash or cash equivalent,M13-740,594186,6302.5
Boston Scientific Corporation,2016-10-17,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,1493.14
Boston Scientific Corporation,2016-10-17,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,365
Boston Scientific Corporation,2016-10-17,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,278.13
Allergan Inc.,2016-10-18,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,4555.25
Allergan Inc.,2016-10-18,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,5828.25
Edwards Lifesciences Corporation,2016-10-19,Cash or cash equivalent,The PARTNER II Trial Placement of Aortic Transcatheter Valve Trial 2010-12,123007,66500
"Penumbra, Inc.",2016-10-19,Cash or cash equivalent,A prospective multicenter registry assessing the embolization of neurovascular lesions using the  Penumbra SMART COIL System,329114,39375
"Siemens Medical Solutions USA, Inc.",2016-10-19,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,15562.5
"Takeda Development Center Americas, Inc.",2016-10-20,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine 5, 10 and 20 mg in Adults With Major Depressive Disorder",316643,999
Cook Research Incorporated,2016-10-24,Cash or cash equivalent,TX2 Post-approval Study,259543,850
Purdue Pharma,2016-10-25,Cash or cash equivalent,063-013,NA,55905.25
Abbott Laboratories,2016-10-28,Cash or cash equivalent,Pivotal Study A Study of the Evalve Cardiovascular Valve Repair System Endovascular Valve Edge to Edge Repair Study EVERESTIIRCT,217198,1147.5
"Actelion Pharmaceuticals US, Inc.",2016-10-28,Cash or cash equivalent,OPUS - AC-055-503,199176,2525
"E.R. Squibb & Sons, L.L.C.",2016-10-28,Cash or cash equivalent,Phase III 1L H N Metastatic,812566,20125
"E.R. Squibb & Sons, L.L.C.",2016-10-28,Cash or cash equivalent,Phase IIIB Dose Comparison N3 I1 vs I3 N1 in melanoma,812566,13125
"InSightec,LTD",2016-10-31,Cash or cash equivalent,A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects,NA,115941
"Medtronic USA, Inc.",2016-11-01,In-kind items and services,SANTE,164924,2390
Pfizer Inc.,2016-11-01,Cash or cash equivalent,Palbociclib PD0332991 Combined With Fulvestrant In Hormone Receptorplus HER2Negative Metastatic Breast Cancer After Endocrine Failure PALOMA3,760719,188
"Roche Diagnostics Operations, Inc.",2016-11-01,In-kind items and services,RD002446,408254,309.26
Sunovion Pharmaceuticals Inc.,2016-11-01,Cash or cash equivalent,APL-130277,1134319,2982
Fisher Scientific Company L.L.C.,2016-11-02,Cash or cash equivalent,MOSES,959823,37250
Novartis Pharmaceuticals Corporation,2016-11-02,Cash or cash equivalent,A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED SUBCUTANEOUSLY VERSUS TERIFLUNOMIDE ADMINISTERED ORALLY IN PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS,74842,6100
"AbbVie, Inc.",2016-11-03,Cash or cash equivalent,A14-464,631489,50633
Edwards Lifesciences Corporation,2016-11-03,In-kind items and services,Compassion S3 2015-01,96907,3248.8
"Zimmer Biomet Holdings, Inc.",2016-11-03,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,1419.69
"Alexion Pharmaceuticals, Inc.",2016-11-04,Cash or cash equivalent,A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies,102421,7442
"Pharmacyclics LLC, An AbbVie Company",2016-11-04,Cash or cash equivalent,PCYC-1112-CA,1251521,1520.71
Boston Scientific Corporation,2016-11-07,Cash or cash equivalent,CAP2 - PREVAIL CONTINUED ACCESS REGISTRY,217198,1625
Pfizer Inc.,2016-11-08,Cash or cash equivalent,Study Of The Blood Thinner Apixaban For Patients Who Have An Abnormal Heart Rhythm Atrial Fibrillation And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm Cardioversion,198456,1250
"Alexion Pharmaceuticals, Inc.",2016-11-09,Cash or cash equivalent,A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies,102421,5750
Edwards Lifesciences Corporation,2016-11-09,In-kind items and services,Compassion S3 2015-01,96907,5552.03
Insulet Corporation,2016-11-09,Cash or cash equivalent,IN SILICO ASSESSMENT OF INACCURATE INSULIN DELIVERY,NA,18156.5
Purdue Pharma,2016-11-09,Cash or cash equivalent,063-013,NA,22018.75
"Genentech, Inc.",2016-11-10,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,10212.5
"Zimmer Biomet Holdings, Inc.",2016-11-10,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,2437.5
"MicroVention, Inc.",2016-11-11,Cash or cash equivalent,HEAT,355275,702
Cook Research Incorporated,2016-11-14,Cash or cash equivalent,Zenith Transection,192614,150
Cook Research Incorporated,2016-11-14,Cash or cash equivalent,NA,NA,100
F. Hoffmann-La Roche AG,2016-11-14,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,14428.71
Pfizer Inc.,2016-11-14,Cash or cash equivalent,Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation,31776,19032
"AbbVie, Inc.",2016-11-16,Cash or cash equivalent,M14-011,596090,3256.84
"AbbVie, Inc.",2016-11-16,Cash or cash equivalent,M14-327,594186,6446.25
"Seattle Genetics, Inc.",2016-11-16,Cash or cash equivalent,SG019A0003,366054,1146.34
"Seattle Genetics, Inc.",2016-11-16,Cash or cash equivalent,SG0350014,366054,2395.5
"Biogen, Inc.",2016-11-17,Cash or cash equivalent,Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) Demonstration Project,NA,1064
Boston Scientific Corporation,2016-11-21,Cash or cash equivalent,STRATEGIC ASSESSMENT OF RANDOMIZED DEFIBRILLATION THERAPY US,187930,365
Boston Scientific Corporation,2016-11-21,Cash or cash equivalent,CLINICAL EVALUATION OF THE BLAZER OPEN-IRRIGATED ABLATION CA,281489,618.76
SANOFI US SERVICES INC.,2016-11-22,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,129.43
Valeant Pharmaceuticals North America LLC,2016-11-22,Cash or cash equivalent,A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER,211357,185
SANOFI US SERVICES INC.,2016-11-23,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,3660
Gilead Sciences Inc,2016-11-29,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,733
"AbbVie, Inc.",2016-11-30,Cash or cash equivalent,M13-740,594186,2717.2
"AbbVie, Inc.",2016-11-30,Cash or cash equivalent,M13-740,594186,3568
"Genentech, Inc.",2016-12-01,Cash or cash equivalent,INDXN MAIN ETRO PBO,594186,3500
"Roche Diagnostics Operations, Inc.",2016-12-01,In-kind items and services,RD002446,408254,170.66
"Siemens Medical Solutions USA, Inc.",2016-12-01,Cash or cash equivalent,NA,300280,1
Eli Lilly and Company,2016-12-05,Cash or cash equivalent,"A PHASE 2 STUDY OF ABEMACICLIB IN PATIENTS WITH BRAIN METASTASES SECONDARY TO HORMONE RECEPTOR POSITIVE BREAST CANCER, NON-SMALL CELL LUNG CANCER, OR MELANOMA",760719,12937.5
F. Hoffmann-La Roche AG,2016-12-05,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,1900
Gilead Sciences Inc,2016-12-06,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,300
Vertex Pharmaceuticals Incorporated,2016-12-06,Cash or cash equivalent,A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis,826949,11595.63
DePuy Orthopaedics Inc.,2016-12-07,Cash or cash equivalent,Multi-Center Prospective Evaluation of Operative vs Non-operative for ASD,147144,3300
Novartis Pharmaceuticals Corporation,2016-12-07,Cash or cash equivalent,AN EVALUATION OF TREATMENT WITH XOLAIROMALIZUMAB TO IMPROVE THE ASTHMATIC RESPONSE TO AN EXPERIMENTAL INFECTION WITH RHINOVIRUS,258995,96649.1
"Takeda Development Center Americas, Inc.",2016-12-07,Cash or cash equivalent,"A Randomized, Double-Blind, Parallel Group, Placebo- and Active-Controlled, Phase 4 Study Evaluating the Effect of Vortioxetine 10 and 20 mg/day vs Paroxetine 20 mg/day on Sexual Functioning in Healthy Subjects Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers",322890,10684.5
"Genentech, Inc.",2016-12-08,Cash or cash equivalent,POC FOR RO6867461 IN DME,250079,16713
"Genentech, Inc.",2016-12-08,Cash or cash equivalent,AVENUE,250079,35887
"Genentech, Inc.",2016-12-09,Cash or cash equivalent,APDL1 BLADDER EAP,266016,14540
"Genentech, Inc.",2016-12-09,Cash or cash equivalent,ATEZOLIZUMAB IN MUSCLE INVASIVE BLADDER CANCER MIBC,266016,8217
"Actelion Pharmaceuticals US, Inc.",2016-12-12,Cash or cash equivalent,QUERI ACHD - AC-052433 USA,475119,800
Allergan Inc.,2016-12-13,Cash or cash equivalent,Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension,77076,2750
Allergan Inc.,2016-12-13,Cash or cash equivalent,Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension,77076,2750
"Medtronic USA, Inc.",2016-12-13,In-kind items and services,SANTE,164924,2390
"Takeda Development Center Americas, Inc.",2016-12-13,Cash or cash equivalent,"A prospective, observational, cohort safety study of vedolizumab for imflammatory disease",594186,3e3
"W. L. Gore & Associates, Inc.",2016-12-13,Cash or cash equivalent,GORE HELEX  Septal Occluder  GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging Confirmed TIA in Patients with Patent Foramen Ovale PFO,220413,500
"W. L. Gore & Associates, Inc.",2016-12-13,Cash or cash equivalent,Gore Research and Development,NA,6400
"Abbvie, Inc.",2016-12-14,In-kind items and services,A14-464,631489,57355.2
"AbbVie, Inc.",2016-12-14,Cash or cash equivalent,M14-011,596090,2062.92
Edwards Lifesciences Corporation,2016-12-14,Cash or cash equivalent,The PARTNER II Trial Placement of Aortic Transcatheter Valve Trial 2010-12,92091,26650
Allergan Inc.,2016-12-15,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,NA,7315
"AbbVie, Inc.",2016-12-19,Cash or cash equivalent,M13-740,594186,991
"MicroVention, Inc.",2016-12-19,Cash or cash equivalent,HEAT,355275,1386
Pfizer Inc.,2016-12-19,Cash or cash equivalent,NA,257796,12500
Pfizer Inc.,2016-12-21,Cash or cash equivalent,Sertraline Pediatric Registry for the Evaluation of Safety SPRITES,81927,4.71
SANOFI US SERVICES INC.,2016-12-22,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,311.16
"W. L. Gore & Associates, Inc.",2016-12-23,Cash or cash equivalent,GORE HELEX  Septal Occluder  GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging Confirmed TIA in Patients with Patent Foramen Ovale PFO,220413,1250
"AbbVie, Inc.",2016-12-27,Cash or cash equivalent,A14-464,631489,75591.5
Allergan Inc.,2016-12-27,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,2500
Allergan Inc.,2016-12-27,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,2500
"Ceterix Orthopaedics, Inc.",2016-12-28,Cash or cash equivalent,Comparative Study of the Ceterix Suture Pattern vs. the FastFix 360 for Meniscus Tears,955960,1251.25
Cook Research Incorporated,2016-12-30,Cash or cash equivalent,NA,NA,4267.51
Cook Research Incorporated,2016-12-30,Cash or cash equivalent,NA,NA,9228
Allergan Inc.,2016-12-31,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,2751.6
Allergan Inc.,2016-12-31,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,662
Allergan Inc.,2016-12-31,Cash or cash equivalent,Safety and Efficacy of Bimatoprost Sustained-Release SR in Patients With Open-Angle Glaucoma or Ocular Hypertension,77076,355.85
Allergan Inc.,2016-12-31,Cash or cash equivalent,Safety and Efficacy of Bimatoprost Sustained-Release SR in Patients With Open-Angle Glaucoma or Ocular Hypertension,77076,372.77
Allergan Inc.,2016-12-31,Cash or cash equivalent,Safety and Efficacy of Bimatoprost Sustained-Release SR in Patients With Open-Angle Glaucoma or Ocular Hypertension,77076,11505.44
Allergan Inc.,2016-12-31,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,62
Allergan Inc.,2016-12-31,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDE",81927,3147.32
AstraZeneca Pharmaceuticals LP,2016-12-31,In-kind items and services,Randomised double blind parallel group multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death myocardial infarction and ischaemic stroke in patients with established Peripheral Artery Disease EUCLID Examining Use of tiCagreLor In paD,82765,15.87
"Siemens Medical Solutions USA, Inc.",2016-12-31,Cash or cash equivalent,UVA2012MR1301Mugler,NA,2e4
Sunovion Pharmaceuticals Inc.,2016-12-31,Cash or cash equivalent,APL-130277,1134319,644.08
Sunovion Pharmaceuticals Inc.,2016-12-31,Cash or cash equivalent,APL-130277,1134319,126.16
Vertex Pharmaceuticals Incorporated,2017-01-01,Cash or cash equivalent,Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor,826949,51763.43
Vertex Pharmaceuticals Incorporated,2017-01-01,Cash or cash equivalent,A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation,826949,48172.99
"Roche Diagnostics Operations, Inc.",2017-01-03,Cash or cash equivalent,RD001915,301828,46798.75
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,468.75
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,210.94
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,468.75
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,656.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,656.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,782.82
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,782.82
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,468.75
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,656.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,46.88
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,468.75
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-01-04,Cash or cash equivalent,BIOFLOW-V,601536,337.5
"Genentech, Inc.",2017-01-04,Cash or cash equivalent,CROHN S DISEASE PROGRAM OLE,594186,1116
"Genentech, Inc.",2017-01-04,Cash or cash equivalent,CROHN S DISEASE PROGRAM COHORT 1 INDUCTION COHORT II MAINTENANCE,594186,1116
"Genentech, Inc.",2017-01-04,Cash or cash equivalent,OLE,594186,1116
Kadmon Corporation LLC,2017-01-04,Cash or cash equivalent,Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment with Tesevatinib on Study KD019-101 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,13769.38
Kadmon Corporation LLC,2017-01-04,In-kind items and services,A Phase 1b 2a Safety Pharmacokinetic and Dose Escalation Study of KD019 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,3223.89
Kadmon Corporation LLC,2017-01-04,In-kind items and services,A Double blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,10.46
Kadmon Corporation LLC,2017-01-04,Cash or cash equivalent,A Phase 1b 2a Safety Pharmacokinetic and Dose Escalation Study of KD019 in Subjects with Autosomal Dominant Polycystic Kidney Disease,279373,16027.75
"Biogen, Inc.",2017-01-05,Cash or cash equivalent,Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) Demonstration Project,NA,7127.5
"Johnson & Johnson Vision Care, Inc.",2017-01-06,Cash or cash equivalent,1330-GOCR-2845982,NA,52482
Abbott Laboratories,2017-01-10,Cash or cash equivalent,Pivotal Study: A Study of the Evalve Cardiovascular Valve Repair System - Endovascular Valve Edge-to-Edge Repair Study (EVERESTIIRCT),217198,945
Emergent Biosolutions Inc.,2017-01-10,Cash or cash equivalent,RSDL,446242,800
"Genentech, Inc.",2017-01-10,Cash or cash equivalent,OPEN LABEL MAINTENANCE TRIAL GLOBAL,594186,1116
"Regeneron Pharmaceuticals, Inc.",2017-01-12,Cash or cash equivalent,"A RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED PHASE 2 STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF REPEATED DOSES OF INTRAVITREAL REGN910-3 IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION",19168,5e3
"Regeneron Pharmaceuticals, Inc.",2017-01-12,Cash or cash equivalent,"A RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED PHASE 2 STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF REPEATED DOSES OF INTRAVITREAL REGN910-3 IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION",19168,4e3
"Actelion Pharmaceuticals US, Inc.",2017-01-13,Cash or cash equivalent,OPUS - AC-055-503,199176,1200
"Aesculap Biologics, LLC",2017-01-13,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartilage of the Knee N3D,243965,52261
NOVARTIS PHARMACEUTICALS CORPORATION,2017-01-14,Cash or cash equivalent,A 24 MONTH RANDOMIZED CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CONCENTRATION CONTROLLED EVEROLIMUS PLUS REDUCED TACROLIMUS COMPARED TO STANDARD TACROLIMUS IN RECIPIENTS OF LIVING DONOR LIVER TRANSPLANTS,19951,11501
Boston Scientific Corporation,2017-01-17,Cash or cash equivalent,ZERO AF,281489,1121.89
Corindus Inc.,2017-01-17,Cash or cash equivalent,Precision Registry,601536,18850
"Genentech, Inc.",2017-01-17,Cash or cash equivalent,INDXN MAIN ETRO PBO,594186,1116
Merck Sharp & Dohme Corporation,2017-01-17,In-kind items and services,"A Multicenter, Randomized, Controlled, Three-Arm, Phase III Study to Evaluate the Safety and Efficacy of Two Dosing Schedules of MK-3475 Compared to Ipilimumab in Patients with Advanced Melanoma",472725,17.86
Pfizer Inc.,2017-01-17,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,25419.4
"Zimmer Biomet Holdings, Inc.",2017-01-17,Cash or cash equivalent,DeNovo NT Stratified Knee Study - 90550,243965,2531.25
"Zimmer Biomet Holdings, Inc.",2017-01-17,Cash or cash equivalent,DeNovo NT Knee LDC Study - 90549,243965,10606.25
Abbott Laboratories,2017-01-18,Cash or cash equivalent,ADVANCE ASO,217198,7377.25
Edwards Lifesciences Corporation,2017-01-18,Cash or cash equivalent,PARTNER3 2015-08,213301,15847
"E.R. Squibb & Sons, L.L.C.",2017-01-18,Cash or cash equivalent,Phase II Sequential Ipi Anti PD 1,157351,57486.82
Gilead Sciences Inc,2017-01-19,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,11500
"Janssen Research & Development, LLC",2017-01-19,Cash or cash equivalent,MulticEnter Trial of Rivaroxaban for Early disCharge of pUlmonaRY Embolism From the Emergency Department  (MERCURY PE),1248026,562.5
"Intercept Pharmaceuticals, Inc.",2017-01-20,Cash or cash equivalent,303,62826,12350
AstraZeneca Pharmaceuticals LP,2017-01-22,Cash or cash equivalent,NA,696192,9e4
AstraZeneca Pharmaceuticals LP,2017-01-22,Cash or cash equivalent,CDXT D1840M00058 MPO-MRI Cardiac Fibrosis,696192,9e4
"Lutonix, Inc.",2017-01-23,Cash or cash equivalent,LTX AV,296287,1050
Allergan Inc.,2017-01-24,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,6298.5
NOVARTIS PHARMACEUTICALS CORPORATION,2017-01-24,Cash or cash equivalent,A 12 MONTH RANDOMIZED RATER AND DOSE BLINDED STUDY TO COMPARE THE EFFICACY AND SAFETY OF FINGOLIMOD TWENTY FIVE HUNDREDTH OF A MG AND HALF OF A MG ADMINISTERED ORALLY ONCE DAILY WITH GLATIRAMER ACETATE 20 MG ADMINISTERED SUBCUTANEOUSLY ONCE DAILY IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS,74842,70204.15
"W. L. Gore & Associates, Inc.",2017-01-24,Cash or cash equivalent,GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs),217198,1562.5
Abbott Laboratories,2017-01-25,Cash or cash equivalent,TactiCath Post Approval Study,281489,937.5
"AbbVie, Inc.",2017-01-25,Cash or cash equivalent,P12-792,826949,527.37
"AbbVie, Inc.",2017-01-25,Cash or cash equivalent,M14-327,594186,2490
SANOFI-AVENTIS U.S. LLC,2017-01-25,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,4080
Sunovion Pharmaceuticals Inc.,2017-01-25,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,3757.7
"AbbVie, Inc.",2017-01-26,Cash or cash equivalent,M14-327,594186,37e3
"AbbVie, Inc.",2017-01-26,Cash or cash equivalent,M16-296,808737,51728.75
"Alexion Pharmaceuticals, Inc.",2017-01-26,Cash or cash equivalent,Atypcial Hemolytic-Uremic Syndrome aHUS Registry,244226,2375
Edwards Lifesciences Corporation,2017-01-27,Cash or cash equivalent,COMPASSION S3 2015-01,217198,62128.3
Eli Lilly and Company,2017-01-27,In-kind items and services,A PHASE 2 MULTICENTER RANDOMIZED PARALLEL-ARM PLACEBO-CONTROLLED STUDY OF LY3074828 IN SUBJECTS WITH ACTIVE CROHNS DISEASE (SERENITY),151740,890.4
SANOFI US SERVICES INC.,2017-01-27,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,11.61
NOVARTIS PHARMACEUTICALS CORPORATION,2017-01-31,Cash or cash equivalent,A RANDOMIZED OPEN LABEL PHASE II STUDY OF WEEKLY GEMCITABINE PLUS PAZOPANIB VERSUS WEEKLY GEMCITABINE ALONE IN THE TREATMENT OF PATIENTS WITH PERSISTENT OR RELAPSED EPITHELIAL OVARIAN FALLOPIAN TUBE OR PRIMARY PERITONEAL CARCINOMA,945020,467398.47
"Zimmer Biomet Holdings, Inc.",2017-01-31,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,8750
Boston Scientific Corporation,2017-02-01,In-kind items and services,PAS2,945724,900
Edwards Lifesciences Corporation,2017-02-01,Cash or cash equivalent,PARTNER3 2015-08,213301,1950
"Genentech, Inc.",2017-02-01,Cash or cash equivalent,ARIETTA,240459,7184
Astellas Pharma Global Development,2017-02-02,Cash or cash equivalent,Molecular markers to differentiate calcineurin inhibitor toxicity from immunological mechanisms associated with progression to kidney dysfunction in kidney transplant recipients,NA,199500
Novocure Inc.,2017-02-02,Cash or cash equivalent,"EF-14  A Prospective, Multi-Center Trial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with newly Diagnosed GBM",279608,9375
"Siemens Medical Solutions USA, Inc.",2017-02-02,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,4606.25
"Siemens Medical Solutions USA, Inc.",2017-02-02,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,6968.75
Edwards Lifesciences Corporation,2017-02-03,Cash or cash equivalent,PARTNER 2006-06,123007,2e3
Boston Scientific Corporation,2017-02-06,Cash or cash equivalent,S ICD PAS,187930,555
"E.R. Squibb & Sons, L.L.C.",2017-02-07,Cash or cash equivalent,A Phase IIIb IV Safety Trial of Nivolumab BMS 936558 in Subjects with Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen,768804,5313
Abbott Laboratories,2017-02-08,Cash or cash equivalent,SCORE,25612,578.13
"NEUROPACE, INC.",2017-02-08,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,4362.5
"NEUROPACE, INC.",2017-02-08,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,4362.5
Astellas Pharma Global Development,2017-02-09,Cash or cash equivalent,Assessment of Myocardial Flow Reserve (and Effects of Exercise Traiing in Patients with Angina and Negative Coronary Angiograms,203646,8717.01
"Genentech, Inc.",2017-02-09,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,13188.75
Pacira Pharmaceuticals Incorporated,2017-02-09,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,187.5
Pacira Pharmaceuticals Incorporated,2017-02-09,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,7500
Pacira Pharmaceuticals Incorporated,2017-02-09,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,5625
Pacira Pharmaceuticals Incorporated,2017-02-09,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,2500
Pacira Pharmaceuticals Incorporated,2017-02-09,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,3750
Edwards Lifesciences Corporation,2017-02-10,Cash or cash equivalent,PARTNER3 2015-08,213301,27829.8
"Janssen Research & Development, LLC",2017-02-10,Cash or cash equivalent,MulticEnter Trial of Rivaroxaban for Early disCharge of pUlmonaRY Embolism From the Emergency Department  (MERCURY PE),1248026,887.5
NOVARTIS PHARMACEUTICALS CORPORATION,2017-02-11,Cash or cash equivalent,A MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF THE SAFETY TOLERABILITY AND EFFECTS ON ARTERIAL STRUCTURE AND FUNCTION OF ACZ885 IN PATIENTS WITH INTERMITTENT CLAUDICATION,1061444,24234.66
"E.R. Squibb & Sons, L.L.C.",2017-02-13,Cash or cash equivalent,Phase III Adjuvant Melanoma Monotherapy,812566,26663.64
Allergan Inc.,2017-02-14,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,10022.5
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,281.25
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-02-14,Cash or cash equivalent,BIOFLOW-V,601536,515.63
NOVARTIS PHARMACEUTICALS CORPORATION,2017-02-14,Cash or cash equivalent,A MULTICENTER RANDOMIZED DOUBLE BLIND PARALLEL GROUP ACTIVE CONTROLLED 8 WEEK STUDY TO EVALUATE THE EFFECT OF LCZ696 VERSUS ENALAPRIL ON CHANGES IN NT PROBNP AND SAFETY AND TOLERABILITY OF IN HOSPITAL INITIATION OF LCZ696 COMPARED TO ENALAPRIL IN HFREF PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATED HEART FAILURE ADHF,199176,108387.55
Pfizer Inc.,2017-02-14,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,109730.75
"E.R. Squibb & Sons, L.L.C.",2017-02-16,Cash or cash equivalent,Evaluating Nulojix Long Term Safety in Transplant,696729,1550
Valeant Pharmaceuticals North America LLC,2017-02-16,Cash or cash equivalent,A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER,211357,1279
"AbbVie, Inc.",2017-02-17,Cash or cash equivalent,M13-740,594186,10145.5
"Genentech, Inc.",2017-02-17,Cash or cash equivalent,APDL1 BLADDER EAP,266016,1250
"Genentech, Inc.",2017-02-17,Cash or cash equivalent,APDL1 BLADDER EAP,266016,4596.6
Sunovion Pharmaceuticals Inc.,2017-02-17,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,150
NOVARTIS PHARMACEUTICALS CORPORATION,2017-02-18,Cash or cash equivalent,PROSPECTIVE COMPARISON OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR ARNI VERSUS ACE INHIBITOR TRIAL TO DETERMINE IMPACT ON SERIOUS EVENTS AFTER MYOCARDIAL INFARCTION PARADISE MI,1043167,14914.91
AstraZeneca Pharmaceuticals LP,2017-02-21,Cash or cash equivalent,Affordability and Real world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Current patterns of P2Y12 receptor inhibitor use provide an excellent opportunity to test the impact of copayment reduction on clinician choice of medication patient adherence and clinical outcomes,1043167,2800
Cook Research Incorporated,2017-02-22,Cash or cash equivalent,Evol Esophageal FC (Benign),648051,75
Edwards Lifesciences Corporation,2017-02-22,Cash or cash equivalent,PARTNER 2006-06,123007,4e3
"E.R. Squibb & Sons, L.L.C.",2017-02-22,Cash or cash equivalent,Evaluation of Acute Rejection Rates in de Novo Renal Transplant Recipients Following Thymoglobulin Induction CNI free Nulojix Belatacept Based Immunosuppression,696729,28145
"NEUROPACE, INC.",2017-02-22,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,8116.54
"NEUROPACE, INC.",2017-02-22,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,8116.54
Sunovion Pharmaceuticals Inc.,2017-02-22,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,68.74
"W. L. Gore & Associates, Inc.",2017-02-22,Cash or cash equivalent,GREAT Global Registry for Endovascular Aortic Treatment,312047,1500
Novo Nordisk AS,2017-02-23,Cash or cash equivalent,NN2211-3659,684755,8450
SANOFI US SERVICES INC.,2017-02-24,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,77.57
Pacira Pharmaceuticals Incorporated,2017-02-27,In-kind items and services,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,1574.98
Pfizer Inc.,2017-02-27,Cash or cash equivalent,DIFFERENTIAL EFFECTS OF CEE AND ESTRADIOL ON BENIGN AND MALIGNANT BREAST RATIONALE WHY CEEBZA IS MOST EFFECTIVE TSEC,335990,46633
Pfizer Inc.,2017-02-27,Cash or cash equivalent,DIFFERENTIAL EFFECTS OF CEE AND ESTRADIOL ON BENIGN AND MALIGNANT BREAST RATIONALE WHY CEEBZA IS MOST EFFECTIVE TSEC,335990,46633
SANOFI-AVENTIS U.S. LLC,2017-02-27,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,300
Novo Nordisk AS,2017-02-28,Cash or cash equivalent,NN2211-3659,684755,2588
Abbott Laboratories,2017-03-02,Cash or cash equivalent,SCORE,25612,750
Abbott Laboratories,2017-03-03,Cash or cash equivalent,Pivotal Study: A Study of the Evalve Cardiovascular Valve Repair System - Endovascular Valve Edge-to-Edge Repair Study (EVERESTIIRCT),217198,2430
"Genentech, Inc.",2017-03-03,Cash or cash equivalent,AVENUE,250079,20990
NOVARTIS PHARMACEUTICALS CORPORATION,2017-03-04,Cash or cash equivalent,AN EVALUATION OF TREATMENT WITH XOLAIROMALIZUMAB TO IMPROVE THE ASTHMATIC RESPONSE TO AN EXPERIMENTAL INFECTION WITH RHINOVIRUS,258995,4604
Boston Scientific Corporation,2017-03-06,Cash or cash equivalent,S ICD PAS,187930,1562.5
Boston Scientific Corporation,2017-03-06,Cash or cash equivalent,S ICD PAS,187930,1085
F. Hoffmann-La Roche AG,2017-03-08,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,953.78
"Siemens Medical Solutions USA, Inc.",2017-03-08,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,5243.75
"Siemens Medical Solutions USA, Inc.",2017-03-08,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,5081.25
Daiichi Sankyo Company LTD,2017-03-10,Cash or cash equivalent,NA,594334,5e5
F. Hoffmann-La Roche AG,2017-03-10,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,34024.86
Celgene Corporation,2017-03-13,Cash or cash equivalent,CC-5013-MCL-001,57874,8743
"Varian Medical Systems, Inc.",2017-03-13,Cash or cash equivalent,Real-time delivery with EPID -U.V.,NA,7e4
"Genentech, Inc.",2017-03-14,Cash or cash equivalent,POC FOR RO6867461 IN DME,250079,30514
"AbbVie, Inc.",2017-03-16,Cash or cash equivalent,M14-011,760719,1950.32
"Arthrex, Inc.",2017-03-16,Cash or cash equivalent,RCT of inlay vs. only biceps tenodesis,112215,6500
Sunovion Pharmaceuticals Inc.,2017-03-16,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,7.89
"Takeda Development Center Americas, Inc.",2017-03-16,Cash or cash equivalent,"A prospective, observational, cohort safety study of vedolizumab for imflammatory disease",594186,6e3
"AbbVie, Inc.",2017-03-20,Cash or cash equivalent,M14-327,594186,3748.75
"Actelion Pharmaceuticals US, Inc.",2017-03-20,Cash or cash equivalent,QUERI ACHD - AC-052433 USA,475119,1400
AstraZeneca Pharmaceuticals LP,2017-03-20,Cash or cash equivalent,Randomized Placebo-controlled single Blind Trial to determine the Safety and Efficacy of Ticagrelor for Maintaining  Patency of Arterio-Venous Fistulae Created for Hemodialysis,368063,23800
SANOFI-AVENTIS U.S. LLC,2017-03-20,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,900
"Genentech, Inc.",2017-03-21,Cash or cash equivalent,ATEZOLIZUMAB IN MUSCLE INVASIVE BLADDER CANCER MIBC,266016,8830.8
Cook Research Incorporated,2017-03-22,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,100
"E.R. Squibb & Sons, L.L.C.",2017-03-22,Cash or cash equivalent,Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix Belatacept Based Immunosuppression,696729,145266.73
"E.R. Squibb & Sons, L.L.C.",2017-03-22,Cash or cash equivalent,Phase IIIB Dose Comparison N3 I1 vs I3 N1 in melanoma,812566,20598.51
"Roche Diagnostics Operations, Inc.",2017-03-23,Cash or cash equivalent,RD002446,408254,14443
"Janssen Research & Development, LLC",2017-03-24,Cash or cash equivalent,"A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study",129137,15512.25
Pfizer Inc.,2017-03-27,Cash or cash equivalent,SPRITES  SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS,81927,500
"TESARO, Inc.",2017-03-27,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,12480
"TESARO, Inc.",2017-03-27,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,35400
"W. L. Gore & Associates, Inc.",2017-03-28,Cash or cash equivalent,GORE HELEX  Septal Occluder / GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients with Patent Foramen Ovale (PFO),220413,4125
F. Hoffmann-La Roche AG,2017-03-29,Cash or cash equivalent,GDC0199 FNHL PHASE II,631489,5999.91
Pfizer Inc.,2017-03-29,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,71722.62
Abbott Laboratories,2017-03-30,Cash or cash equivalent,ADVANCE ASO,217198,3e3
Abbott Laboratories,2017-03-30,Cash or cash equivalent,ADVANCE ASO,217198,2500
"Ceterix Orthopaedics, Inc.",2017-03-31,Cash or cash equivalent,Comparative Study of the Ceterix Suture Pattern vs. the FastFix 360 for Meniscus Tears,955960,3040
CorMatrix Cardiovascular Inc.,2017-03-31,Cash or cash equivalent,Perform,312047,7105.65
"W. L. Gore & Associates, Inc.",2017-03-31,Cash or cash equivalent,Evaluation of the Conformable GORE TAG Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection,147662,4e3
Boston Scientific Corporation,2017-04-03,Cash or cash equivalent,S ICD PAS,187930,730
"Penumbra, Inc.",2017-04-05,Cash or cash equivalent,SMART A prospective multicenter registry assessing the embolization of neurovascular lesions using the Penumbra SMART COIL System,329114,53050
"Penumbra, Inc.",2017-04-05,Cash or cash equivalent,SMART A prospective multicenter registry assessing the embolization of neurovascular lesions using the Penumbra SMART COIL System,329114,1875
"Seattle Genetics, Inc.",2017-04-05,Cash or cash equivalent,SG0CD33A0005,206269,18497.5
Cook Research Incorporated,2017-04-06,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,4466.07
Cook Research Incorporated,2017-04-06,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,7142
"Lutonix, Inc.",2017-04-06,Cash or cash equivalent,LTX AV,296287,525
Abbott Laboratories,2017-04-10,Cash or cash equivalent,Evaluation of XIENCE PRIME Everolimus Eluting Stent System (EECSS) or XIENCE V EECSS or XIENCE Xpedition EECSS or XIENCE PRO EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization,601536,3279
"AbbVie, Inc.",2017-04-10,Cash or cash equivalent,M13-740,594186,898
Cook Research Incorporated,2017-04-10,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,1500
"MicroVention, Inc.",2017-04-10,Cash or cash equivalent,HEAT,355275,546
"MicroVention, Inc.",2017-04-10,Cash or cash equivalent,HEAT,355275,693
BIOTRONIK INC.,2017-04-11,Cash or cash equivalent,BIOFLOW-V,601536,656.25
BIOTRONIK INC.,2017-04-11,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-04-11,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-04-11,Cash or cash equivalent,BIOFLOW-V,601536,515.63
BIOTRONIK INC.,2017-04-11,Cash or cash equivalent,BIOFLOW-V,601536,281.25
Incyte Corporation,2017-04-11,Cash or cash equivalent,"A Phase 2 Pilot Trial of an Indoleamine 2, 3, dioxygenase 1 IDO1 Inhibitor INCB024360 Plus a Multipeptide Melanoma Vaccine MELITAC 12.1 in Patients with Advanced Melanoma",157351,3e4
"Aesculap Biologics, LLC",2017-04-13,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartiage of the Knee N3D,243965,19566
Allergan Inc.,2017-04-13,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,2398.75
Pfizer Inc.,2017-04-13,Cash or cash equivalent,MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED  PHASE 3 TRIAL OF FULVESTRANT FASLODEX REGISTERED WITH OR WITHOUT  PD0332991 PALBOCICLIB  GOSERELIN IN WOMEN WITH HORMONE  RECEPTORPOSITIVE HER2NEGATIVE METASTATIC BREAST CANCER  WHOSE DISEASE PROGRESSED AFTER PRIOR ENDOCRINE THERAPY,760719,7795
"Teva Pharmaceuticals USA, Inc.",2017-04-15,Cash or cash equivalent,SD-809-C-23,322890,195
"Teva Pharmaceuticals USA, Inc.",2017-04-15,Cash or cash equivalent,SD-809-C-23,322890,195
"AbbVie, Inc.",2017-04-17,Cash or cash equivalent,A14-464,631489,50633
Eli Lilly and Company,2017-04-17,Cash or cash equivalent,A PHASE II STUDY OF THE COMBINATION OF LY3023414 AND NECITUMUMAB AFTER FIRST-LINE CHEMOTHERAPY FOR METASTATIC SQUAMOUS NON-SMALL CELL CARCINOMA OF THE LUNG,808737,23819
"W. L. Gore & Associates, Inc.",2017-04-17,Cash or cash equivalent,GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs),217198,1250
Pfizer Inc.,2017-04-18,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,108309.6
"Zimmer Biomet Holdings, Inc.",2017-04-18,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,19061.25
"Zimmer Biomet Holdings, Inc.",2017-04-18,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,380
Abbott Laboratories,2017-04-19,Cash or cash equivalent,TactiCath Post Approval Study,281489,1723.75
"Alexion Pharmaceuticals, Inc.",2017-04-19,Cash or cash equivalent,Atypcial Hemolytic-Uremic Syndrome aHUS Registry,244226,375
Edwards Lifesciences Corporation,2017-04-19,Cash or cash equivalent,PARTNERII 2010-12,123007,40500
Cook Research Incorporated,2017-04-21,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,1500
"Janssen Research & Development, LLC",2017-04-21,Cash or cash equivalent,A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression,322890,5e3
SANOFI-AVENTIS U.S. LLC,2017-04-24,Cash or cash equivalent,NA,1043167,830
"AbbVie, Inc.",2017-04-25,Cash or cash equivalent,M14-327,594186,1226.25
Eli Lilly and Company,2017-04-25,In-kind items and services,"A PHASE 2 STUDY OF ABEMACICLIB IN PATIENTS WITH BRAIN METASTASES SECONDARY TO HORMONE RECEPTOR POSITIVE BREAST CANCER, NON-SMALL CELL LUNG CANCER, OR MELANOMA",760719,75
"E.R. Squibb & Sons, L.L.C.",2017-04-25,Cash or cash equivalent,Phase III Multiple Myeloma 3L Combo nivo elo,1356541,15125
Novo Nordisk Inc,2017-04-25,Cash or cash equivalent,Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes,NA,198445.8
SANOFI US SERVICES INC.,2017-04-25,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,114.46
"Zimmer Biomet Holdings, Inc.",2017-04-25,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,5687.5
Abbott Laboratories,2017-04-26,Cash or cash equivalent,Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial),217198,8175
Abbott Laboratories,2017-04-26,Cash or cash equivalent,ADVANCE ASO,217198,4958
Abbott Laboratories,2017-04-26,Cash or cash equivalent,SCORE,25612,390.63
CorMatrix Cardiovascular Inc.,2017-05-01,Cash or cash equivalent,Carotid Registry,188640,4318
Sorin Group USA Inc.,2017-05-02,Cash or cash equivalent,Mitroflow DL PAS TMT001 - University of Virginia Site,188640,6700
"Takeda Development Center Americas, Inc.",2017-05-02,Cash or cash equivalent,"A Randomized, Double-Blind, Parallel Group, Placebo- and Active-Controlled, Phase 4 Study Evaluating the Effect of Vortioxetine 10 and 20 mg-Day vs Paroxetine 20 mg-Day on Sexual Functioning in Healthy Subjects",322890,4777
Abbott Laboratories,2017-05-09,Cash or cash equivalent,Pivotal Study: A Study of the Evalve Cardiovascular Valve Repair System - Endovascular Valve Edge-to-Edge Repair Study (EVERESTIIRCT),288649,3240
Merck Sharp & Dohme Corporation,2017-05-09,In-kind items and services,A phase II trial of concurrent chemoradiation with consolidation MK-3475 for the treatment of inoperable or unresectable stage III non-small cell lung cancer NSCLC LUN14-179,285695,29940.96
Vertex Pharmaceuticals Incorporated,2017-05-09,Cash or cash equivalent,A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis,826949,356.25
"Genentech, Inc.",2017-05-11,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,9593.75
Boston Scientific Corporation,2017-05-15,Cash or cash equivalent,CAP2,217198,562.5
Boston Scientific Corporation,2017-05-15,Cash or cash equivalent,S ICD PAS,187930,365
Merck Sharp & Dohme Corporation,2017-05-15,In-kind items and services,"A TRIAL TO EVALUATE THE SAFETY, IMMUNOGENICITY, AND CLINICAL ACTIVITY OF A HELPER PEPTIDE VACCINE PLUS PD-1 BLOCKADE",157351,29940.96
Valeant Pharmaceuticals North America LLC,2017-05-15,Cash or cash equivalent,A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER,211357,185
NOVARTIS PHARMACEUTICALS CORPORATION,2017-05-17,Cash or cash equivalent,A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED SUBCUTANEOUSLY VERSUS TERIFLUNOMIDE ADMINISTERED ORALLY IN PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS,74842,8271.58
"Actelion Pharmaceuticals US, Inc.",2017-05-19,Cash or cash equivalent,OPUS - AC-055-503,199176,5650
Novocure Inc.,2017-05-23,Cash or cash equivalent,"EF-14  A Prospective, Multi-Center Trial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with newly Diagnosed GBM",279608,3050
Cook Research Incorporated,2017-05-24,Cash or cash equivalent,Zenith Dissection Endovascular System pivotal stud,312047,3100
SANOFI-AVENTIS U.S. LLC,2017-05-24,Cash or cash equivalent,NA,1043167,2230
Cook Research Incorporated,2017-05-25,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,3350
Eli Lilly and Company,2017-05-25,In-kind items and services,A PHASE 2 MULTICENTER RANDOMIZED PARALLEL-ARM PLACEBO-CONTROLLED STUDY OF LY3074828 IN SUBJECTS WITH ACTIVE CROHNS DISEASE (SERENITY),159516,37.5
"Genentech, Inc.",2017-05-25,Cash or cash equivalent,AVENUE,250079,12295
"AbbVie, Inc.",2017-05-30,Cash or cash equivalent,M14-327,594186,1226.25
Pfizer Inc.,2017-05-31,Cash or cash equivalent,A RANDOMIZED OPENLABEL MULTICENTER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB MSB0010718C IN COMBINATION WITH ANDOR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER  JAVELIN OVARIAN 100,945020,19950
Edwards Lifesciences Corporation,2017-06-02,Cash or cash equivalent,PARTNERII 2010-12,123007,18250
"Roche Diagnostics Operations, Inc.",2017-06-06,Cash or cash equivalent,RD002446,408254,3975
"Seattle Genetics, Inc.",2017-06-06,Cash or cash equivalent,SG0350014,366054,1250
"Siemens Medical Solutions USA, Inc.",2017-06-06,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,7912.5
Sorin Group USA Inc.,2017-06-07,Cash or cash equivalent,Perceval S Sutureless Heart Valve Study TPS002,729525,41725
"TESARO, Inc.",2017-06-08,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,14187.5
Eli Lilly and Company,2017-06-12,Cash or cash equivalent,"A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED PHASE II STUDY OF ENZALUTAMIDE WITH OR WITHOUT THE PI3 KINASE-MTOR INHIBITOR LY3023414 IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER",266016,1250
"Genentech, Inc.",2017-06-12,Cash or cash equivalent,AVENUE,250079,6876
"Rivanna Medical, LLC",2017-06-12,Cash or cash equivalent,MD-ANES Low-Cost Handheld Medical Device for Neuroaxial Anesthesia Guidance in the Obese,NA,79115
"W. L. Gore & Associates, Inc.",2017-06-13,Cash or cash equivalent,GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs),217198,4312.5
Allergan Inc.,2017-06-15,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,931
"Exactech, Inc.",2017-06-15,Cash or cash equivalent,A Prospective Multi-center Data Collection to Assess the Exactech Guided Personalized Surgery eGPS in Total Knee Arthroplasty,233499,10812.5
"Exactech, Inc.",2017-06-15,Cash or cash equivalent,A Prospective Multi-center Data Collection to Assess the Exactech Guided Personalized Surgery eGPS in Total Knee Arthroplasty,233499,26718.75
"Exactech, Inc.",2017-06-15,Cash or cash equivalent,A Prospective Multi-center Data Collection to Assess the Exactech Guided Personalized Surgery eGPS in Total Knee Arthroplasty,233499,5125
"Intercept Pharmaceuticals, Inc.",2017-06-16,Cash or cash equivalent,303,62826,1500
Boston Scientific Corporation,2017-06-19,Cash or cash equivalent,S ICD PAS,187930,825
GENZYME CORPORATION,2017-06-20,Cash or cash equivalent,Q1 2017 Gaucher LSD Registry,NA,325
GENZYME CORPORATION,2017-06-20,Cash or cash equivalent,Q1 2017 Fabry LSD Registry,NA,150
Vertex Pharmaceuticals Incorporated,2017-06-20,Cash or cash equivalent,A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis,826949,10091
AstraZeneca Pharmaceuticals LP,2017-06-21,Cash or cash equivalent,ASPENAZThe Rector and Visitors of the University of Virginia Alexander L. Klibanovno. unique identifier since PhD 708501,NA,1e4
Edwards Lifesciences Corporation,2017-06-21,Cash or cash equivalent,PARTNER3 2015-08,213301,11958.74
"Genentech, Inc.",2017-06-21,Cash or cash equivalent,ATEZOLIZUMAB IN MUSCLE INVASIVE BLADDER CANCER MIBC,266016,11038.5
Edwards Lifesciences Corporation,2017-06-23,Cash or cash equivalent,COMPASSION S3 2015-01,217198,9886.5
"Intercept Pharmaceuticals, Inc.",2017-06-23,Cash or cash equivalent,303,62826,6533.1
"AbbVie, Inc.",2017-06-26,Cash or cash equivalent,M14-327,594186,1e3
SANOFI-AVENTIS U.S. LLC,2017-06-26,Cash or cash equivalent,NA,1043167,700
"Genentech, Inc.",2017-06-27,Cash or cash equivalent,POC FOR RO6867461 IN DME,250079,8500
Phadia US Inc.,2017-06-27,In-kind items and services,"Investigation of IgG4 and IgE Antibodies to the component proteins of Milk, Other Foods and inhalants associated with EoE",210401,82294
"Acorda Therapeutics, Inc",2017-06-28,Cash or cash equivalent,TOZ-CL06,1134319,13945
Cook Research Incorporated,2017-06-28,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,700
Cook Research Incorporated,2017-06-28,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,50
"MicroVention, Inc.",2017-06-28,Cash or cash equivalent,HEAT,355275,2772
Cook Research Incorporated,2017-06-29,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,5578
Cook Research Incorporated,2017-06-29,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,2930.63
"Aziyo Biologics, Inc.",2017-06-30,Cash or cash equivalent,Perform,312047,762
Boston Scientific Corporation,2017-07-03,Cash or cash equivalent,ASAP TOO,217198,6500
"Intercept Pharmaceuticals, Inc.",2017-07-03,Cash or cash equivalent,303,62826,5913.1
"AbbVie, Inc.",2017-07-05,Cash or cash equivalent,M14-011,760719,2437.9
"Aesculap Biologics, LLC",2017-07-07,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartiage of the Knee N3D,243965,2828
"Arthrex, Inc.",2017-07-07,Cash or cash equivalent,RCT of inlay vs. only biceps tenodesis,112215,375
"Janssen Research & Development, LLC",2017-07-07,Cash or cash equivalent,"A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study",129137,2775
"Medical Device Business Services, Inc.",2017-07-12,Cash or cash equivalent,A Pivotal Study Comparing Two Injections of MONOVISC to Two Injections of Saline in Patients with Osteoarthritis of the Hip,250357,625
Abbott Laboratories,2017-07-13,Cash or cash equivalent,Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial),217198,6150
Merck Sharp & Dohme Corporation,2017-07-13,In-kind items and services,"A Multicenter, Randomized, Controlled, Three-Arm, Phase III Study to Evaluate the Safety and Efficacy of Two Dosing Schedules of MK-3475 Compared to Ipilimumab in Patients with Advanced Melanoma",472725,17.86
Boston Scientific Corporation,2017-07-17,Cash or cash equivalent,S ICD PAS,187930,1125
Boston Scientific Corporation,2017-07-17,Cash or cash equivalent,S ICD PAS,187930,365
"E.R. Squibb & Sons, L.L.C.",2017-07-17,Cash or cash equivalent,Phase III 1L H N Metastatic,812566,24214
Pfizer Inc.,2017-07-18,Cash or cash equivalent,PROTEIN AGGREGATION EFFECTS ON RESIN FOULING IN THE CHROMATOGRAPHIC OF MONOCLONIAL ANTIBODIES,NA,81658
"Zimmer Biomet Holdings, Inc.",2017-07-18,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,2818.75
"Zimmer Biomet Holdings, Inc.",2017-07-18,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,2818.75
"Alexion Pharmaceuticals, Inc.",2017-07-19,Cash or cash equivalent,Atypcial Hemolytic-Uremic Syndrome aHUS Registry,244226,750
Pfizer Inc.,2017-07-19,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,89253.03
Abbott Laboratories,2017-07-20,Cash or cash equivalent,Evaluation of XIENCE PRIME Everolimus Eluting Stent System (EECSS) or XIENCE V EECSS or XIENCE Xpedition EECSS or XIENCE PRO EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization,601536,2217
"AbbVie, Inc.",2017-07-20,Cash or cash equivalent,P12-792,826949,236.84
"Actelion Pharmaceuticals US, Inc.",2017-07-21,Cash or cash equivalent,OPUS - AC-055-503,199176,2400
"TESARO, Inc.",2017-07-24,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,35400
"TESARO, Inc.",2017-07-24,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"TESARO, Inc.",2017-07-24,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"TESARO, Inc.",2017-07-24,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,35400
"TESARO, Inc.",2017-07-24,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"TESARO, Inc.",2017-07-24,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,35400
Cook Research Incorporated,2017-07-25,Cash or cash equivalent,Zenith Dissection Endovascular System pivotal stud,312047,3e3
"AbbVie, Inc.",2017-07-26,Cash or cash equivalent,M14-327,594186,125
"E.R. Squibb & Sons, L.L.C.",2017-07-27,Cash or cash equivalent,Ph I II 1L SCLC Combo w Platinum and Etoposide,808737,7e3
"Penumbra, Inc.",2017-07-27,Cash or cash equivalent,SMART A prospective multicenter registry assessing the embolization of neurovascular lesions using the Penumbra SMART COIL System,329114,19375
"Penumbra, Inc.",2017-07-27,Cash or cash equivalent,SMART A prospective multicenter registry assessing the embolization of neurovascular lesions using the Penumbra SMART COIL System,329114,47612.5
"Regeneron Pharmaceuticals, Inc.",2017-07-28,Cash or cash equivalent,Alirocumab and Plaque Regression in Peripheral Arterial Disease,1061444,80087.53
Corindus Inc.,2017-07-31,Cash or cash equivalent,Precision GRX Registry,601536,1500
"Janssen Research & Development, LLC",2017-07-31,Cash or cash equivalent,"A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study",129137,7504.87
SANOFI-AVENTIS U.S. LLC,2017-07-31,Cash or cash equivalent,NA,1043167,300
Sunovion Pharmaceuticals Inc.,2017-07-31,In-kind items and services,PEDIATRIC OPEN-LABEL EXTENSION STUDY,81927,85
"Siemens Medical Solutions USA, Inc.",2017-08-01,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,1500
"TESARO, Inc.",2017-08-01,Cash or cash equivalent,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",945020,20230.2
Pfizer Inc.,2017-08-03,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,104828
"Genentech, Inc.",2017-08-04,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,7045
"Johnson & Johnson Vision Care, Inc.",2017-08-04,Cash or cash equivalent,1330-GOCR-2845982,NA,52481
Boston Scientific Corporation,2017-08-07,Cash or cash equivalent,CAP2,217198,1687.5
Pacira Pharmaceuticals Incorporated,2017-08-07,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,8059.48
"AbbVie, Inc.",2017-08-08,Cash or cash equivalent,M16-296,808737,20426.25
"LivaNova USA, Inc.",2017-08-08,Cash or cash equivalent,Mitroflow DL PAS TMT001,188640,5150
"Siemens Medical Solutions USA, Inc.",2017-08-08,Cash or cash equivalent,Blood collection from emergency department cardiac patient volunteers: Protocol no. MCSA-Multiplatform-201303.PRO,931365,630
"Zimmer Biomet Holdings, Inc.",2017-08-08,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,812.5
"Genentech, Inc.",2017-08-10,Cash or cash equivalent,A MULTICENTER OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY OF LAMPALIZUMAB,19168,3726
"Penumbra, Inc.",2017-08-10,Cash or cash equivalent,SMART A prospective multicenter registry assessing the embolization of neurovascular lesions using the Penumbra SMART COIL System,329114,14062.5
"TESARO, Inc.",2017-08-10,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,16640
"TESARO, Inc.",2017-08-10,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
"TESARO, Inc.",2017-08-10,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,16640
"TESARO, Inc.",2017-08-10,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
"TESARO, Inc.",2017-08-10,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,16640
"TESARO, Inc.",2017-08-10,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
Cook Research Incorporated,2017-08-11,Cash or cash equivalent,Evol Esophageal FC (Benign),648051,75
Merck Sharp & Dohme Corporation,2017-08-15,In-kind items and services,A phase II trial of concurrent chemoradiation with consolidation MK-3475 for the treatment of inoperable or unresectable stage III non-small cell lung cancer NSCLC LUN14-179,1112054,14664.96
"AbbVie, Inc.",2017-08-17,Cash or cash equivalent,M16-296,808737,1e3
Boston Scientific Corporation,2017-08-21,Cash or cash equivalent,S ICD PAS,187930,365
Boston Scientific Corporation,2017-08-21,Cash or cash equivalent,ASAP TOO,217198,4255.32
Edwards Lifesciences Corporation,2017-08-21,Cash or cash equivalent,PARTNERII 2010-12,123007,7600
SANOFI-AVENTIS U.S. LLC,2017-08-21,Cash or cash equivalent,NA,1043167,600
Abbott Laboratories,2017-08-22,Cash or cash equivalent,Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial),217198,1500
Astellas US Technologies,2017-08-22,In-kind items and services,Assessment of Myocardial Flow Reserve (and Effects of Exercise Traiing in Patients with Angina and Negative Coronary Angiograms,203646,28206.57
"Smith & Nephew, Inc.",2017-08-22,In-kind items and services,NA,4225543,19356
"Smith & Nephew, Inc.",2017-08-22,In-kind items and services,NA,4225543,6078
Pfizer Inc.,2017-08-28,Cash or cash equivalent,SPRITES  SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS,81927,510
SANOFI US SERVICES INC.,2017-08-28,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,32.42
"AbbVie, Inc.",2017-08-29,In-kind items and services,A14-464,631489,275.2
"AbbVie, Inc.",2017-08-29,In-kind items and services,A14-464,631489,688.32
GENZYME CORPORATION,2017-08-29,Cash or cash equivalent,Q2 2017 Fabry LSD Registry,NA,75
GENZYME CORPORATION,2017-08-29,Cash or cash equivalent,Q2 2017 MPSI LSD Registry,NA,125
GENZYME CORPORATION,2017-08-29,Cash or cash equivalent,Q2 2017 Pompe LSD Registry,NA,175
GENZYME CORPORATION,2017-08-29,Cash or cash equivalent,Q2 2017 Gaucher LSD Registry,NA,300
"TESARO, Inc.",2017-08-29,Cash or cash equivalent,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",945020,22750
Sunovion Pharmaceuticals Inc.,2017-08-31,In-kind items and services,PEDIATRIC OPEN-LABEL EXTENSION STUDY,81927,85
"Genentech, Inc.",2017-09-01,Cash or cash equivalent,A PHASE III TRIAL IN ADJUVANT HER2 BC PTS,760719,1900
Novo Nordisk Inc,2017-09-04,Cash or cash equivalent,Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes,NA,5326.2
"AbbVie, Inc.",2017-09-05,Cash or cash equivalent,M16-296,808737,3700
"Medical Device Business Services, Inc.",2017-09-07,Cash or cash equivalent,A Pivotal Study Comparing Two Injections of MONOVISC to Two Injections of Saline in Patients with Osteoarthritis of the Hip,250357,577.5
"TESARO, Inc.",2017-09-08,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,6679.8
Incyte Corporation,2017-09-13,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,15.64
Incyte Corporation,2017-09-14,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,120
Incyte Corporation,2017-09-14,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,54.99
Novo Nordisk Inc,2017-09-14,Cash or cash equivalent,Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes,NA,2663.1
Cook Research Incorporated,2017-09-15,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,100
Cook Research Incorporated,2017-09-15,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,1200
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,100.66
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,39
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,50
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,9.41
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,59.53
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,494.94
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,16.5
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,54.99
Incyte Corporation,2017-09-15,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,400.6
Sunovion Pharmaceuticals Inc.,2017-09-15,In-kind items and services,PEDIATRIC OPEN-LABEL EXTENSION STUDY,81927,5.75
"W. L. Gore & Associates, Inc.",2017-09-15,Cash or cash equivalent,GORE HELEX  Septal Occluder / GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients with Patent Foramen Ovale (PFO),220413,1687.5
Boston Scientific Corporation,2017-09-18,Cash or cash equivalent,ASAP TOO,217198,4640.95
"E.R. Squibb & Sons, L.L.C.",2017-09-19,Cash or cash equivalent,A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Dose Ranging Phase 2b Study of the Safety and Efficacy of Continuous 48 Hour Intravenous Infusions of BMS 986231 in Hospitalized Patients with Heart Failure and Impaired Systoli,1248026,39426.13
"AbbVie, Inc.",2017-09-20,Cash or cash equivalent,M14-327,594186,7803.75
"AbbVie, Inc.",2017-09-20,Cash or cash equivalent,M14-011,760719,1769.08
"Genentech, Inc.",2017-09-20,Cash or cash equivalent,POC FOR RO6867461 IN DME,250079,5268
Insulet Corporation,2017-09-20,Cash or cash equivalent,IN SILICO ASSESSMENT OF INACCURATE INSULIN DELIVERY,NA,18156.5
SANOFI-AVENTIS U.S. LLC,2017-09-20,Cash or cash equivalent,NA,1043167,1130
"AbbVie, Inc.",2017-09-21,Cash or cash equivalent,M14-327,594186,5245
"Genentech, Inc.",2017-09-25,Cash or cash equivalent,ATEZOLIZUMAB IN MUSCLE INVASIVE BLADDER CANCER MIBC,266016,8830.8
"Medical Device Business Services, Inc.",2017-09-25,Cash or cash equivalent,A Pivotal Study Comparing Two Injections of MONOVISC to Two Injections of Saline in Patients with Osteoarthritis of the Hip,250357,8750
Pfizer Inc.,2017-09-25,Cash or cash equivalent,SPRITES  SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS,81927,1250
"TESARO, Inc.",2017-09-25,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
"TESARO, Inc.",2017-09-25,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
"Varian Medical Systems, Inc.",2017-09-25,Cash or cash equivalent,Real-time delivery with EPID -U.V.,NA,7e4
Allergan Inc.,2017-09-26,Cash or cash equivalent,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",81927,313
Novo Nordisk Inc,2017-09-26,Cash or cash equivalent,Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes,NA,2361.5
SANOFI US SERVICES INC.,2017-09-26,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,369.6
"TESARO, Inc.",2017-09-26,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,4160
"TESARO, Inc.",2017-09-26,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,4160
Cook Research Incorporated,2017-09-27,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,6724
Cook Research Incorporated,2017-09-27,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,4225.51
Edwards Lifesciences Corporation,2017-09-27,Cash or cash equivalent,PARTNERII 2010-12,123007,1e4
Prometheus Laboratories Inc.,2017-09-28,In-kind items and services,Low-dose Interleukin-2 and Pembrolizumab Among Patients with Metastatic Melanoma and Renal CEll Carcinoma,698625,203682
"Ceterix Orthopaedics, Inc.",2017-09-29,Cash or cash equivalent,Study Name:  Comparative Study of the Ceterix Suture Pattern vs. the FastFix 360 for Meniscus Tears,955960,1848.75
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,39.7
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,134.16
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,161.16
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,41.24
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,46.8
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,38.2
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,71.58
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,80.2
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,6.8
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,3.8
Incyte Corporation,2017-09-29,Cash or cash equivalent,A phase 3 randomized open label multi center study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft vs. host disease after allogenic stem cell transplantation,206269,38.2
"Aziyo Biologics, Inc.",2017-09-30,Cash or cash equivalent,Perform,312047,685.8
"AbbVie, Inc.",2017-10-02,In-kind items and services,A14-464,631489,137.6
"AbbVie, Inc.",2017-10-02,In-kind items and services,A14-464,631489,688.32
Boston Scientific Corporation,2017-10-02,Cash or cash equivalent,ASAP TOO,217198,1674.69
"Intercept Pharmaceuticals, Inc.",2017-10-02,Cash or cash equivalent,303,62826,2644.2
"Intercept Pharmaceuticals, Inc.",2017-10-02,Cash or cash equivalent,303,62826,842.4
"TESARO, Inc.",2017-10-03,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,6639.3
"TESARO, Inc.",2017-10-03,Cash or cash equivalent,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",945020,5116.5
"CardioFocus, Inc.",2017-10-04,Cash or cash equivalent,Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System-Adaptive Contact,281489,5e3
"Arthrex, Inc.",2017-10-05,Cash or cash equivalent,RCT of inlay vs. only biceps tenodesis,112215,375
"Exactech, Inc.",2017-10-05,Cash or cash equivalent,A Prospective Multi-center Data Collection to Assess the Exactech Guided Personalized Surgery eGPS in Total Knee Arthroplasty,233499,10875
"TESARO, Inc.",2017-10-05,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
"TESARO, Inc.",2017-10-05,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,7160
"TESARO, Inc.",2017-10-05,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,23600
"Janssen Research & Development, LLC",2017-10-06,Cash or cash equivalent,A Phase 2 Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies,266016,13e3
"Janssen Research & Development, LLC",2017-10-06,Cash or cash equivalent,A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression,322890,20368
Gilead Sciences Inc,2017-10-09,Cash or cash equivalent,"RESCUE: A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies",212626,1300
"Roche Diagnostics Operations, Inc.",2017-10-10,Cash or cash equivalent,RD003141,408254,4862.5
"Takeda Development Center Americas, Inc.",2017-10-10,Cash or cash equivalent,"A Randomized, Double-Blind, Parallel Group, Placebo- and Active-Controlled, Phase 4 Study Evaluating the Effect of Vortioxetine 10 and 20 mg-Day vs Paroxetine 20 mg-Day on Sexual Functioning in Healthy Subjects",322890,3444
"Takeda Development Center Americas, Inc.",2017-10-10,Cash or cash equivalent,"A Randomized, Double-Blind, Parallel Group, Placebo- and Active-Controlled, Phase 4 Study Evaluating the Effect of Vortioxetine 10 and 20 mg-Day vs Paroxetine 20 mg-Day on Sexual Functioning in Healthy Subjects",322890,1500
Ascensia Diabetes Care US Inc.,2017-10-12,In-kind items and services,Clinical Acceptance of the Artificial Pancreas- the International Diabetes Closed Loop -iDCL- Trial,1115890,14601.62
"TESARO, Inc.",2017-10-12,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"TESARO, Inc.",2017-10-12,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,11800
"TESARO, Inc.",2017-10-12,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,11800
"TESARO, Inc.",2017-10-12,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"Zimmer Biomet Holdings, Inc.",2017-10-12,Cash or cash equivalent,MarrowStim PAD Kit Study,570554,325
"Aesculap Biologics, LLC",2017-10-13,Cash or cash equivalent,NOVOCART 3D for the Treatment of Articular Cartiage of the Knee N3D,243965,6208
"Regeneron Pharmaceuticals, Inc.",2017-10-13,Cash or cash equivalent,Alirocumab and Plaque Regression in Peripheral Arterial Disease,1061444,28e3
Boston Scientific Corporation,2017-10-16,Cash or cash equivalent,S ICD PAS,187930,190
Pfizer Inc.,2017-10-18,Cash or cash equivalent,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,31776,97956.88
Pfizer Inc.,2017-10-18,Cash or cash equivalent,A RANDOMIZED OPENLABEL MULTICENTER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB MSB0010718C IN COMBINATION WITH ANDOR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER  JAVELIN OVARIAN 100,945020,12740
Allergan Inc.,2017-10-19,Cash or cash equivalent,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",81927,6e3
Allergan Inc.,2017-10-19,Cash or cash equivalent,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",81927,2500
Novocure Inc.,2017-10-19,Cash or cash equivalent,"EF-25 Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)",92911,6688
"Pharmacyclics LLC, An AbbVie Company",2017-10-19,Cash or cash equivalent,PCYC-1112-CA,129137,2942.31
"Pharmacyclics LLC, An AbbVie Company",2017-10-19,Cash or cash equivalent,PCYC-1112-CA,129137,14984.12
"Actelion Pharmaceuticals US, Inc.",2017-10-20,Cash or cash equivalent,OPUS - AC-055-503,199176,3125
Orthofix International N.V.,2017-10-20,Cash or cash equivalent,CP-1504TEPL,31776,2500
Abbott Laboratories,2017-10-23,Cash or cash equivalent,Evaluation of XIENCE PRIME Everolimus Eluting Stent System (EECSS) or XIENCE V EECSS or XIENCE Xpedition EECSS or XIENCE PRO EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization,601536,2186
"LivaNova USA, Inc.",2017-10-23,Cash or cash equivalent,Mitroflow DL PAS TMT001,188640,650
Pfizer Inc.,2017-10-23,Cash or cash equivalent,SPRITES  SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS,81927,625
Phadia AB,2017-10-23,In-kind items and services,Idiopathic Anaphylaxis and Alpha Gal,210401,15.62
"Zimmer Biomet Holdings, Inc.",2017-10-25,Cash or cash equivalent,Comprehensive Shoulder System with Nano Humeral Component IDE Study,112215,8437.5
Novocure Inc.,2017-10-26,Cash or cash equivalent,"EF-25 Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)",92911,13125
Novo Nordisk AS,2017-10-26,Cash or cash equivalent,NN2211-3659,684755,3437.5
SANOFI US SERVICES INC.,2017-10-26,In-kind items and services,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,19.54
Edwards Lifesciences Corporation,2017-10-27,Cash or cash equivalent,PARTNER3 2015-08,213301,12592.15
Orthofix International N.V.,2017-10-27,Cash or cash equivalent,CP-1703CSPM,31776,6250
"Regeneron Pharmaceuticals, Inc.",2017-10-27,Cash or cash equivalent,Alirocumab and Plaque Regression in Peripheral Arterial Disease,1061444,7e3
"TESARO, Inc.",2017-10-31,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,11800
"TESARO, Inc.",2017-10-31,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"TESARO, Inc.",2017-10-31,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,8320
"TESARO, Inc.",2017-10-31,In-kind items and services,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,11800
Abbott Laboratories,2017-11-01,Cash or cash equivalent,SCORE,25612,578.13
Allergan Inc.,2017-11-02,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,300
Allergan Inc.,2017-11-02,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,1e4
"W. L. Gore & Associates, Inc.",2017-11-03,Cash or cash equivalent,GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs),217198,6750
"W. L. Gore & Associates, Inc.",2017-11-03,Cash or cash equivalent,GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs),217198,6e3
Boston Scientific Corporation,2017-11-06,Cash or cash equivalent,ZERO AF,281489,84.36
Boston Scientific Corporation,2017-11-06,Cash or cash equivalent,CAP2,217198,562.5
"Genentech, Inc.",2017-11-06,Cash or cash equivalent,A PHASE III MULTICENTER RANDOMIZED DOUBLE MASKED,19168,3837.5
NOVARTIS PHARMACEUTICALS CORPORATION,2017-11-06,Cash or cash equivalent,A SINGLE ARM OPEN LABEL MULTICENTER STUDY EVALUATING THE LONG TERM SAFETY AND TOLERABILITY OF HALF OF A MG FINGOLIMOD FTY720 ADMINISTERED ORALLY ONCE DAILY IN PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS,74842,925
"Zimmer Biomet Holdings, Inc.",2017-11-07,Cash or cash equivalent,Efficacy of the BioWick SureLock Implant for the Reattachment of Soft Tissue to Bone in Subjects Undergoing Rotator Cuff Repairs,1338423,4e3
Edwards Lifesciences Corporation,2017-11-08,Cash or cash equivalent,COMPASSION S3 2015-01,217198,6500
"Roche Diagnostics Operations, Inc.",2017-11-09,Cash or cash equivalent,RD003141,408254,5587.5
"TESARO, Inc.",2017-11-09,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,6679.8
Allergan Inc.,2017-11-14,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,2622
"E.R. Squibb & Sons, L.L.C.",2017-11-14,Cash or cash equivalent,A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer CHECKMATE 920,956611,27915
"Genentech, Inc.",2017-11-14,Cash or cash equivalent,A MULTICENTER OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY OF LAMPALIZUMAB,19168,2300
"NEUROPACE, INC.",2017-11-14,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,50
"NEUROPACE, INC.",2017-11-14,Cash or cash equivalent,RNS System Long-term Treatment Clinical Investigation,164924,50
"TESARO, Inc.",2017-11-14,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,2320
Merck Sharp & Dohme Corporation,2017-11-15,In-kind items and services,"A Multicenter, Randomized, Controlled, Three-Arm, Phase III Study to Evaluate the Safety and Efficacy of Two Dosing Schedules of MK-3475 Compared to Ipilimumab in Patients with Advanced Melanoma",472725,17.86
Cook Research Incorporated,2017-11-16,Cash or cash equivalent,Zenith Transection,300280,425
Cook Research Incorporated,2017-11-16,Cash or cash equivalent,Zenith Dissection Endovascular System pivotal stud,312047,250
Edwards Lifesciences Corporation,2017-11-17,Cash or cash equivalent,PARTNERII 2010-12,123007,20550
"Janssen Research & Development, LLC",2017-11-17,Cash or cash equivalent,A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression,322890,9473
Pfizer Inc.,2017-11-17,In-kind items and services,NA,257796,12500
Allergan Inc.,2017-11-21,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,300
Allergan Inc.,2017-11-21,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,300
Allergan Inc.,2017-11-21,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,300
Allergan Inc.,2017-11-21,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,300
"TESARO, Inc.",2017-11-21,Cash or cash equivalent,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",945020,5737.5
SANOFI US SERVICES INC.,2017-11-22,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,700
"E.R. Squibb & Sons, L.L.C.",2017-11-30,Cash or cash equivalent,Phase III Nivo ipi vs Nivo in Stage IIIb c or IV Adjuvant Melanoma,812566,35512.05
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,93.6
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,81.04
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,140.64
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,11.36
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,77.52
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,229.2
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,17.04
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,263.56
Incyte Corporation,2017-11-30,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease",369474,481.2
"Janssen Research & Development, LLC",2017-11-30,Cash or cash equivalent,An Open-label Long-term Extension Safety Study of Intranasal Esketamine in Treatment-resistant Depression,322890,5e3
Edwards Lifesciences Corporation,2017-12-01,Cash or cash equivalent,PARTNER3 2015-08,213301,17198.41
"Roche Diagnostics Operations, Inc.",2017-12-01,In-kind items and services,RD003141,408254,5462.01
"AbbVie, Inc.",2017-12-04,In-kind items and services,A14-464,631489,28389.9
Boston Scientific Corporation,2017-12-04,Cash or cash equivalent,S ICD PAS,187930,365
Boston Scientific Corporation,2017-12-04,Cash or cash equivalent,ASAP TOO,217198,2520.94
Pacira Pharmaceuticals Incorporated,2017-12-04,Cash or cash equivalent,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF EXPAREL FOR POSTSURGICAL PAIN MANAGEMENT IN SUBJECTS UNDERGOING OPEN LUMBAR SPINAL FUSION SURGERY",838313,16467.7
Allergan Inc.,2017-12-05,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,300
"Medical Device Business Services, Inc.",2017-12-05,Cash or cash equivalent,A Pivotal Study Comparing Two Injections of MONOVISC to Two Injections of Saline in Patients with Osteoarthritis of the Hip,250357,4990
"TESARO, Inc.",2017-12-05,Cash or cash equivalent,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",945020,5922
"PTC Therapeutics, Inc.",2017-12-06,Cash or cash equivalent,"Phase 2 Muliticenter Randomized, Double-Masked Placebo-controlled study of the safety and efficacy of Ataluren for the treatment of Nonsense Mutations of Aniridia (STAR)",350117,17403.75
"Medical Device Business Services, Inc.",2017-12-08,Cash or cash equivalent,A Pivotal Study Comparing Two Injections of MONOVISC to Two Injections of Saline in Patients with Osteoarthritis of the Hip,250357,2510
"Janssen Research & Development, LLC",2017-12-11,Cash or cash equivalent,The Rector and Visitors of the University of Virginia Neurosciences - General,NA,125e3
"MicroVention, Inc.",2017-12-11,Cash or cash equivalent,HEAT,355275,693
Corindus Inc.,2017-12-12,Cash or cash equivalent,Precision GRX Registry,601536,7e3
ONY Biotech Inc.,2017-12-12,Cash or cash equivalent,AERO-02,408254,14400
"W. L. Gore & Associates, Inc.",2017-12-12,Cash or cash equivalent,GORE HELEX  Septal Occluder / GORE  Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients with Patent Foramen Ovale (PFO),220413,562.5
"Aziyo Biologics, Inc.",2017-12-13,Cash or cash equivalent,Perform,312047,1524
Cook Research Incorporated,2017-12-13,Cash or cash equivalent,Zenith Branch Endovascular Graft-Iliac Bifurcation,300280,200
Edwards Lifesciences Corporation,2017-12-13,Cash or cash equivalent,COMPASSION S3 2015-01,217198,48456.2
"Intercept Pharmaceuticals, Inc.",2017-12-15,Cash or cash equivalent,303,62826,1041.6
"Intercept Pharmaceuticals, Inc.",2017-12-15,Cash or cash equivalent,303,62826,2747.7
Pfizer Inc.,2017-12-15,Cash or cash equivalent,SPRITES  SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NONINTERVENTIONAL LONGITUDINAL COHORT STUDY TO EVALUATE THE EFFECTS OF LONGTERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS,81927,510
Boston Scientific Corporation,2017-12-18,Cash or cash equivalent,S ICD PAS,187930,625
"Genentech, Inc.",2017-12-18,Cash or cash equivalent,ATEZOLIZUMAB IN MUSCLE INVASIVE BLADDER CANCER MIBC,266016,15
"Ceterix Orthopaedics, Inc.",2017-12-19,Cash or cash equivalent,Comparative Study of the Ceterix Suture Pattern vs. the FastFix 360 for Meniscus Tears,955960,1331.25
"Genentech, Inc.",2017-12-19,Cash or cash equivalent,POC FOR RO6867461 IN DME,250079,1443
"TESARO, Inc.",2017-12-19,Cash or cash equivalent,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",945020,5085.9
Cook Research Incorporated,2017-12-20,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,2032
Cook Research Incorporated,2017-12-20,Cash or cash equivalent,Cook IVC Filter Post-Market Study,300280,2022.24
SANOFI US SERVICES INC.,2017-12-20,Cash or cash equivalent,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",1043167,2250
"Medical Device Business Services, Inc.",2017-12-21,Cash or cash equivalent,A Pivotal Study Comparing Two Injections of MONOVISC to Two Injections of Saline in Patients with Osteoarthritis of the Hip,250357,1175
"TESARO, Inc.",2017-12-21,Cash or cash equivalent,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,760719,2480
"AbbVie, Inc.",2017-12-22,Cash or cash equivalent,M13-740,594186,1784.5
Sunovion Pharmaceuticals Inc.,2017-12-22,In-kind items and services,PEDIATRIC OPEN-LABEL EXTENSION STUDY,81927,6.36
Sunovion Pharmaceuticals Inc.,2017-12-22,In-kind items and services,PEDIATRIC OPEN-LABEL EXTENSION STUDY,81927,0.43
Sunovion Pharmaceuticals Inc.,2017-12-22,In-kind items and services,PEDIATRIC OPEN-LABEL EXTENSION STUDY,81927,6.36
Sunovion Pharmaceuticals Inc.,2017-12-22,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,0.59
Sunovion Pharmaceuticals Inc.,2017-12-22,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,281.35
Sunovion Pharmaceuticals Inc.,2017-12-22,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,11.23
Sunovion Pharmaceuticals Inc.,2017-12-22,Cash or cash equivalent,LURASIDONE PEDIATRIC BIPOLAR STUDY,81927,5.15
Allergan Inc.,2017-12-26,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,313
Allergan Inc.,2017-12-26,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,2500
Allergan Inc.,2017-12-26,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,250
Allergan Inc.,2017-12-26,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,9e3
"AbbVie, Inc.",2017-12-27,Cash or cash equivalent,M14-011,760719,975.16
"Janssen Research & Development, LLC",2017-12-29,Cash or cash equivalent,An Open-label Long-term Extension Safety Study of Intranasal Esketamine in Treatment-resistant Depression,322890,2817
Allergan Inc.,2017-12-31,Cash or cash equivalent,"A MULTICENTER, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,662
Allergan Inc.,2017-12-31,Cash or cash equivalent,"A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER",81927,380
Allergan Inc.,2017-12-31,Cash or cash equivalent,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION",81927,668
Allergan Inc.,2017-12-31,Cash or cash equivalent,AN OPEN-LABEL LONG-TERM SAFETY STUDY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER,81927,62
AstraZeneca Pharmaceuticals LP,2017-12-31,In-kind items and services,Affordability and Real world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Current patterns of P2Y12 receptor inhibitor use provide an excellent opportunity to test the impact of copayment reduction on clinician choice of medication patient adherence and clinical outcomes,1043167,9.22
"Aziyo Biologics, Inc.",2017-12-31,Cash or cash equivalent,Perform,312047,1949.45
Draegerwerk AG & Co. KGaA,2017-12-31,In-kind items and services,Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects,NA,20748
"NEUROPACE, INC.",2017-12-31,In-kind items and services,RNS System Long-term Treatment Clinical Investigation,164924,25950
"NEUROPACE, INC.",2017-12-31,In-kind items and services,RNS System Long-term Treatment Clinical Investigation,164924,25950
